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Abstract 
Psychiatric advance directives (PADs) are an emerging method for adults with serious and 
persistent mental illness to manage their treatment by documenting treatment preferences in 
advance of periods of incapacity.  However, the application of PADs has largely been 
neglected by the legal and psychiatric discourse in New Zealand.  This paper presents some 
of the key purposes and unrealised benefits of PADs, and explains why New Zealand’s law 
and policy surrounding advance directives in the mental health arena is unclear compared to 
other jurisdictions.  Though interviews conducted with New Zealand clinicians and consumer 
advocates, key practical and legal dilemmas around forming, monitoring, and enforcing 
PADs were extracted and dissected.  Interviews elucidated that, while attitudes were 
generally positive attitude towards PADs in the mental health system, the lack of a focused 
PAD strategy stifled its promulgation where it could most benefit service users. This paper 
proposes that PADs should be promoted, and articulates a normative PAD strategy for New 
Zealand.  
 
Word length 
The text of this paper (excluding abstract, table of contents, footnotes and bibliography) 
comprises approximately 15,078 words. 
 
 
Subjects and Topics 
Advance Directives in Mental Health  
Mental Health (Compulsory Assessment and Treatment) Act 1992 
Medical Best Practice  
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I  Introduction  
Psychiatric advance directives (PADs) are at the forefront of contemporary measures to 
reduce the involuntary treatment and detention of persons with mental illness.  Embodying 
the slogan “nothing about us, without us”,1 PADs are helpful strategies that give people with 
mental disorders more say in the management of their treatment.
2
  However, the application 
of advanced directives in the mental health arena is particularly contentious and has largely 
been neglected by legal and psychiatric discourse in New Zealand.
3
  To date, no information 
has been collected domestically on the number of people, although the estimated numbers are 
very low.
4
  This paper proposes that PADs should be promoted, and articulates a New 
Zealand-specific PAD strategy.  
International jurisprudence has praised the use of PADs in modern psychiatry.  Honouring the 
choices of individuals with disabilities when they are vulnerable and lack mental capacity has 
been labelled an international human rights issue that cannot be overlooked.
5
  PADs have 
been described as a solution which promotes patient autonomy, empowerment and self-
determination.
6
  However, literature also details the technical and legal difficulties in making, 
monitoring and enforcing advance directives in practice.
7
  The lack of consumer 
understanding of the legal status of PADs and clinical scepticism over a document which is 
meant to limit treatment powers has resulted in a relatively small uptake and even smaller 
levels of clinical recommendation to patients. 
New Zealand has a weak model of recognising PADs in law.  Without a national PAD 
strategy, it can be assumed that the enforcement of PADs has been inconsistent, particularly 
due to varying patient circumstances, resource availability and differences in clinical opinion.  
Patients who would benefit from executing a PAD are not likely to see the value of creating 
                                               
1 Ross Phillips “Consumer Participation in Mental Health Research” (2006) 27 Social Policy Journal of New 
Zealand 171 at 171. 
2 Australian Capital Territory Department of Health Review of the ACT Mental Health (Treatment and Care) Act 
1994 (Department of Health, Options Paper, November 2007) at 20.  
3 Pamela Wareham “New Zealanders making advance directives: A discourse analysis” (Masters in Health 
Science Thesis, Auckland University of Technology, 2005) at 22. 
4 Confidential interview with a psychiatrist, 4 September 2013.     
5
 United Nation General Assembly Convention on the Rights of Persons with Disabilities: Resolution (adopted 
by the General Assembly 24 January 2007, A/RES/61/106) [UN Convention Rights]; World Health 
Organisation “WHO Resource Book on Mental Health, Human Rights and Legislation” (2005) WHO Library 
Cataloguing-in-Publication Data <www.who.int/mental_health/> at 17. 
6 Penelope Weller New Law and Ethics in Mental Health Advance Directives: the Convention on the Rights of 
Persons with Disabilities and the Right to Choose (Routledge, New York, 2013) at 10. 
7 Srebnik and Brodoff “Implementing Psychiatric Advance Directives: Service Provider Issues and Answers” 
(2003) 30(3) Journal of Behavioural Health Services and Research 253. 
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them because it is perceived that they can simply be overridden by New Zealand’s mental 
health legislation. 
A good mental health service engages with relevant parties in collaborative discourse, so a 
focal point of this paper is the identification of the normative role of the parties surrounding 
the making, monitoring, and enforcement of PADs.  What types of patients would benefit 
from making a PAD?  Who should bear the burden of recommending and educating patients 
on PADs? And, who should attest to the validity of the PAD during enforcement?  In 
answering these questions, this paper acknowledges the tension between providing a 
personalised health care service and the issue of finite resources and strains on health 
practitioners’ time.   
This paper firstly outlines the purpose of making a PAD in a mental health system that is 
increasingly becoming more open to patient choice, and less to clinical paternalism.  This 
section introduces the different models of PADs, and how the content and form of the PAD 
will influence their enforceability in practice.  Secondly, this paper analyses the precarious 
legal status of PADs in New Zealand law, and make comparisons to leading PAD 
jurisdictions including Scotland and the United States.    
Part VI offers a window to the New Zealand attitudes towards PADs in mental health 
practice. Clinicians promoted the concept PADs but were wary of the increased strain on 
clinical practice, and burden on resources and time.  Advocates had seen firsthand the 
usefulness of PADs for patient empowerment, and recommended their legal fortification.  All 
participants agreed that PADs were underutilised, and its benefits under-recognised.  From 
interviews conducted with a small group of leading mental health clinicians and advocates 
within the Wellington region, an interesting disparity in opinions was highlighted. 
Based on the limited interviews, this paper explores both the legal and practical issues faced 
by stakeholders in the making, monitoring and enforcement of PADs.  Many of the issues are 
backed by international literature, but how to address them is not clarified in our current 
advance directive framework.  Finally this paper recommends a stronger and more 
transparent framework for PADs in New Zealand, where key actors are educated about their 
role in the system. 
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II Background to Advance Directives in Mental Health 
A Scope of the paper 
This paper refers to advance directives in mental health as psychiatric advance directives 
(PADs).  The paper focuses on treatment advance directives rather than personal statements 
about general life planning when a person loses capacity.  The PADs discussed refer 
exclusively to written instructional directives rather than oral or proxy directives.  This paper 
uses the terms ‘patient’, ‘service-user’, and ‘consumer’ interchangeably. 
B History of PADs 
Advance directive instruments, or living wills, resemble the traditional last will and 
testament.
8
  Advance directives were originally developed to allow persons to make decisions 
in relation to their end-of-life care, such as decisions to withdraw life support treatment (“do 
not resuscitate” orders),9 but they have subsequently been applied to mental health care.  
Generally, PADs enable individuals with mental illness to declare treatment preferences in 
the event of future mental incapacity.
10
  PADs generally only come into force after the person 
loses capacity or is incompetent to state their wishes. 
Historically, the field of mental health has been governed by a desire among individuals with 
mental illness to break free from unwanted medical paternalism.
11
  Some perceive advance 
directives as legal instruments that allow patients to oppose a historical tradition of this 
paternalism.
12
  Individuals with mental illness are keenly aware of the unequal bargaining 
power that can exist in making decisions with their physicians.  Advance directives were seen 
as a pre-emptive tool to avoid unwanted medical treatment.
13
 
 
 
                                               
8 Tony Bogdanoski “Psychiatric advance directives: the new frontier in mental health law reform in Australia?”  
(2009) 16 JLM 891 at 892.  
9 RL O’Reilly “The Capacity to Execute an Advance Directive for Psychiatric Treatment” (2008) 31(1) Int’l JL 
& Psychiatry 66 at 66. 
10
 J Swanson and others “Superseding Psychiatric Advance Directives: Ethical and Legal Considerations” 
(2006) 34(3) Journal of the American Academy of Psychiatry and the Law 385 at 394. 
11 A B Rich “Medical Paternalism v Respect for Patient Autonomy: The More Things Change the More They 
Remain the Same” (2006) 10 Michigan State University College of Law Journal of Medicine and Law 87 at 89. 
12 D L Ambrosini “Psychiatric Advance Directives, Autonomy, and Choice: An Interdisciplinary Perspective 
from Law, Ethics, and Medicine” (Doctor of Philosophy Thesis, McGill University, 2011) at 55. 
13 Rosenson and Kasten “Another view of autonomy: arranging for consent in advance” (1991) 17 
Schizophrenia Bulletin 1 at 1. 
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C General Advance Directives vs PADs 
PADs can be distinguished from general advance directives in physical health care in three 
major aspects.  First, people filling out general health care directives are often making 
decisions about end-of-life treatments they have never actually experienced.
14
  In contrast, 
psychiatric patients are generally dealing with chronic illness, and are therefore likely to have 
experienced the treatments they are describing.  For example, a patient with schizophrenia, 
for example, may have opinions about which antipsychotic drug is most effective, and which 
ones have not worked in the past.
15
   
Secondly, the goal of general advance directives is to increase the chance that life ends in 
comfort and dignity, whereas the goal of a psychiatric directive is often to maximise the 
chance of recovery while minimising unwanted interventions.
16
  More recent jurisprudence 
has recognised the power of PADs to give effect to patient participation and the human rights 
approach to recovery in mental health.
17
  
Thirdly, the consequences of enforcing a general advance directive may also be different to 
enforcing PADs.  Refusing treatment in end-of-life situations will usually hasten death.  This 
can be seen as positive for the person (this is what they wanted) and arguably for their family, 
since not only have they respected the person’s wishes but also do not have to watch a family 
member suffer.
18
  Refusing treatment for a mental illness is different to physical illness in that 
it is unlikely to lead to death.  However, a possible result of following a refusal of treatment 
in a PAD is that the patient could become severely ill and remain ill in hospital for longer 
than if treated.
19
 
 
                                               
14 Bogdanoski, above n 8, at 892.  
15
 At 893.  
16 Jacqueline M Atkinson Advance Directives in Mental Health (Jessica Kingsley Publishers, London, 2007) at 
22; Harvard Health Publications “Making the most of psychiatric advance directives” (Mental Health Letter, 6 
April 2006) at 1. 
17 P Weller “Psychiatric Advance Directives and Human Rights” 17(2) Journal of Psychology and Law 218 at 
219. 
18 Atkinson, above n 16, at 23. 
19
 At 24. 
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III  Reasons to promote PAD usage in Literature 
Approximately one in five New Zealanders suffer from some form of mental illness at some 
point in their lives.
20
  In 2009/2010, the District Health Board (DHB) saw 120,293 mental 
health clients.
21
  In a New Zealand health system which seeks to increase patient involvement 
and cooperation between clinician and patient and recognise the rights of the mentally ill, the 
use of PADs should be promoted.  The following section elaborates on the justification for 
the increased use of PADs by service users in New Zealand 
A What type of patients benefit from making a PAD? 
Unlike end-of-life situations that people may be able to imagine even from a young age, few 
people are likely to envisage developing a reoccurring mental illness and losing capacity.  
Therefore, the expectation is that a PAD will be made only by (or is only appropriate for) 
people who have experienced a major mental illness.
22
  This group of people are prone to 
having an acute episode in the future and therefore the most likely to find an advance 
directive useful.
23
  Information on which to base preferences specified in PADs will usually 
be derived from past treatment experiences as well as dialogue with treatment providers and 
others involved in a patient’s life.24  Other groups that may take an interest in PADs include 
people who are at high risk of developing a major mental illness through genetic link,
25
 and 
those with poor language or other verbal communication abilities.
26
   
B Purpose for making PADs 
1 Therapeutic effect  
A strong argument for protecting and increasing awareness of PADs is that they provide a 
mechanism to include the patient’s “voice” during a mental health crises, when consumers 
are often least likely to have meaningful participation in treatment decisions.
27
  Nobody 
                                               
20 M Oakley Brown, J E Wells and K M Scott (eds) Te Rau Hinengaro: The New Zealand Mental Health Survey 
(Ministry of Health, September 2006) at 15. 
21 Ministry of Health Mental Health and Addiction: Service Use 2009/10 (February 2013) at 8. 
22 Papageorgiou and others “Advance directives for patients compulsorily admitted to hospital with serious 
mental illness” (2002) 181 British Journal of Psychiatry 513 at 513; Srebnik and others “The content and 
clinical utility of psychiatric advance directives” (2005) 56 Psychiatric services 592 at 598. 
23 Atkinson, above n 16 at 133.   
24 Srebnik and Brodoff, above n 7, at 257. 
25 Atkinson, above n 16, at 23. 
26 Jacqueline M Atkinson Advance Directives in Mental Health (Jessica Kingsley Publishers, London, 2007) at 
134. 
27
 Srebnik and Brodoff, above n 7, at 254.  
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understands an individual’s needs and experiences as much as the individual themselves, and 
people react very differently to the same treatment.
28
  So unlike proxy directives, 
instructional PADs can accurately reflect the wants and needs of the patient, using the 
individual’s own words.29   
Through increased consumer participation, it has been argued that very execution of a PAD is 
therapeutic as it “provokes people who suspect that their problems might escalate to prepare 
treatment early, before the condition gets out of hand”.30  Therefore, PADs can also support 
planned, effective crisis treatment by identifying and mobilising resources to de-escalate 
crises and serve as viable alternatives to hospitalisation.
31
 
An often overlooked advantage of PADs is that the process of completing such documents 
allows individuals to gain insight, and learn how to self-manage their mental illness.  For 
instance, individuals with depression are better able to deal with their illness when they are 
engaged as active participants rather than merely asked to comply with treatment.
32
   
It has been accepted that coercive treatment does not work as well as treatment which is the 
subject of patient choice because of the therapeutic value deriving from a mutual dialogue 
and acceptance between patient and therapist.
33
  It follows that, in cases where a patient is 
capable of giving or refusing consent, it could be prudent to seek the patient’s consent to 
foster the therapeutic relationship in spite of the statutory mandate to treat without consent. 
2  Avoiding re-traumatisation 
In particular circumstances, a PAD may be created directly in response to a bad experience 
with treatment.  The PAD could refer to refusals of treatment or care which are catalysts for a 
previous traumatic experience.  If adhered to, the PAD can prevent re-traumatisation where 
an individual relives the same negative experiences from a previous treatment or life event.  
For example, a patient who has suffered from sexual abuse or rape may be reminded of this 
                                               
28 Confidential interview with a consumer advocate, 4 September 2013.   
29 Bogdanoski, above n 8, at 893.  
30
 B Winick “Advance Directive Instruments For Those with Mental Illness” (1996) 51 U Miami L Rev 57 at 
68.  
31 Srebnik and Brodoff, above n 7, at 254. 
32 Dan Bilsker, Elliot M Goldner and Wayne Jones “Health Service Patterns Indicate Potential Benefit of 
Supported Self-Management of Depression in Primary Care” (2007) 52(2) Canadian Journal of Psychiatry 86 at 
95.  
33 Sylvia Bell and Warren Brookbanks Mental Health Law in New Zealand (2nd ed, Brookers Ltd, Wellington, 
2005) at [19.5]. 
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traumatic time if pinned down (or put in other forms of restraint) during compulsory 
treatment. 
Without a PAD, and being unable to communicate, a common example of re-trauma can 
occur in the follow situation.  During a recent hospitalisation, a patient struggles to explain to 
psychiatrists that certain anti-psychotic drug, especially Haldol, exacerbates their tardive 
dyskinesia – a neurological syndrome causing involuntary, rhythmic and often grotesque 
movements of the fact, lips and tongue.
34
  Dismissing the patient as incapable of speaking for 
themselves, the psychiatrist prescribed Haldol over the patient’s protest.  The unwanted 
treatment and associated loss of control left the patient opting for homelessness over the 
prospect of confinement.
35
 
3  Patient autonomy and empowerment  
Making an advance directive is about the exercise of autonomy – the autonomy of the 
competent person to decide their treatment in accordance with the principle of informed 
consent.
36
   This may be exercised in different ways.  Opting out of the treatment may be 
motivated by the desire of the well person to preserve more of the autonomy by avoiding the 
side-effects of some treatments.
37
  Equally, the motivation to opt out may have to do with 
preserving the ‘autonomy’ of the person when ill, or indeed, the existence of the ill person.38   
However, opting into treatment may have more to do with preserving the autonomy of the 
well person.  For most people this would be assumed to be the rational choice.  Often they are 
also choosing the timing of the treatment as well as the type of treatment.  Although the 
autonomy of the competent person may be limiting the capacity of the future incompetent 
person, this is generally accepted given the competent person is giving informed consent.        
4  Avoiding the stigma of coercive treatment 
PADs can avoid the stigma of the formal scheduling process and provide an alternative to 
legal coercion.  Formal civil commitment proceedings, or the “scheduling” of involuntary 
patients, could be limited if patients included provisions in a PAD instrument to the effect 
                                               
34
 18 Former State Mental Health Commissioners, the National Mental Health Association, and Others ‘Brief of 
18 Former State Mental Health Commissioners, The National Mental Health Association, and others as Amici 
Curiae in support of the Appellees’, Submission in Hargrave v Vermont 02-7160, 3 July 2002, at 12. 
35 At 12. 
36 B Winick “The Right to Refuse Mental Health Treatment: A Therapeutic Jurisprudence Analysis” (1994) 17 
Int’l JL & Psychiatry 99 at 100–111.   
37 Bogdanoski, above n 8, at 899. 
38
 Atkinson, above 16, at 82. 
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that certain treatment or hospitalisation be provided to them on a voluntary basis 
notwithstanding an incompetent refusal by the patient.
39
  Such “voluntary commitment 
contracts” would benefit those patients in particular who have previously had positive 
hospital experiences, but found the scheduling process to be demeaning, and can foresee 
future periods of civil commitment due to the relapsing nature of their mental illness.
40
      
5 Information sharing 
For clinicians and practitioners, PADs can serve as a repository for patient histories on 
treatment preferences.
41
  In particular, for clinicians treating a patient with whom they have 
had no previous history, a PAD provides insightful information on treatments that have 
proven effective on the patient.  A PAD that specifies treatment that has previously been 
successful or very unsuccessful may help a clinician not make the same mistake again.  On a 
wider scale, there may also be improved communication between users, family members and 
providers in the sense that a consensus about appropriate forms of treatment can be met and 
set in place before crisis.
42
  The New Zealand Medical Association recognises the advantages 
of advance statements in terms of encouraging openness, dialogue and forward planning 
between all parties involved in making and enforcing PADs.
43
   
 6 PADs protecting bodily integrity  
PAD gives people who suffer from mental illness – and who are more likely to be subjective 
to coercive treatment – a voice to reject medication that puts their general health at risk.44  
Even when administered correctly, psychotropic drugs have been known to have particularly 
severe side effects, and in extreme cases could cause fatality.
45
  They are described to 
“intervene in the deepest functions of personhood” and “are mind altering”.46  Although the 
new atypical anti-psychotic drugs are deemed safer, it has still been known to cause weight-
gain, sexual dysfunction, and significantly increase the chance of developing diabetes 
                                               
39 Winick, above n 30, at 68. 
40 A Buchanan and D Brock Deciding for Others: The Ethics of Surrogate Decision Making (Cambridge 
University Press, London 1990) at 351. 
41 18 Former State Mental Health Commissioners, the National Mental Health Association, and Others, above n 
34, at 6. 
42 At 8. 
43 New Zealand Medical Association “Advance Directives” (2007) New Zealand Medical Association website 
<//www.nzma.org.nz/>.    
44 Robert Bernstein “Commentary: The Climate for Physician Adherence to Psychiatric Advance Directives” 
(2006) 34(3) The Journal of American Academy of Psychiatry and the Law 402 at 402. 
45 J Dunlap “Psychiatric Advance Directives: Having One’s Say?” (2001) 89 Kentucky Law Journal 327 at 368. 
46
 Steinkruger v Miller (2000) 612 NW 2d 591 at 597 at [15]. 
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mellitus.  PADs give people a platform to expressly refuse these treatments on grounds of 
bodily integrity.
47
   
 
IV Legal status of PADS   
General advance directives are given legal status by the common law, although many 
jurisdictions have specifically enacted PAD legislation to fortify their status.  It is common 
amongst most legal jurisdictions that an advance directive is ‘trumped’ by the use of a Mental 
Health Act which allows for compulsory treatment, even if the person objects and has so 
stated in an advance directive.
48
  This section compares the New Zealand legal status of 
PADs to two leading jurisdictions, Scotland and United States, as well as a developing 
jurisdiction, Australia.  It is argued that New Zealand’s weak status for PADs is a major 
contributing factor to their underutilisation.   
A Weak or Strong model 
This dimension concerns how binding the advance directive is on treating clinicians (and 
possibly others) – in other words their status in law.49  In Commonwealth jurisdictions the 
legislatures have tended to place mental health advance directives in weak legal 
frameworks.
50
   
In New Zealand, the Code of Health and Disability Services Consumers’ Rights 1996 (The 
Code) creates a weak model of protection of PADs, making them subordinate to mental 
health laws.  This approach reflects an assumption that weak recognition of mental health 
advance directives will encourage the development of good clinical practices.
51
  However, 
this is not true in New Zealand’s case.  The weak model is typically justified on the basis that 
the purpose of such laws is to clarify the common law, promote rights, and rebut the 
prevailing assumption that the principles of advance care planning do not apply in mental 
health settings.   
                                               
47 18 Former State Mental Health Commissioners, the National Mental Health Association, and Others, above n 
34, at 19.  
48 Phil Barker (ed) Mental Health Ethics: the Human Context (Routledge, New York, 2011) at 749. 
49 Atkinson, above n 16, at 47. 
50 Weller, above n 6, at 160. 
51
 At 160. 
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B  New Zealand 
New Zealand takes a minimalist approach to recognising PADs.  Right 7(5) of the Code 
allows consumers to use an advance directive in accordance with the common law.
52
  The 
phrase “advance directive” is defined in cl 4 to mean: 
A written or oral directive – 
(a) by which a consumer makes a choice about a possible future health care procedure; and 
(b) that is intended to be effective only when he or she is not competent. 
Right 7(7) provides that “every consumer has the right to refuse services and to withdraw 
consent to services”.53  Both of these rights are derived from s 11 of the New Zealand Bill of 
Rights Act 1990, which provides for the right to refuse to undergo treatment, and is 
underpinned by the principle of autonomy.
54
 While other jurisdictions have specific 
legislation setting out requirements to be met before an advance directive is legally valid,
55
 
there is no equivalent legislative clarification in New Zealand. Moreover, the validity of 
advance directives at common law is unclear in New Zealand.
56
  What is clear is that a PAD 
will not override the ability of a clinician to authorise compulsory treatment if the patient is 
subject to a compulsory treatment order under the Mental Health (Compulsory Assessment 
and Treatment) Act 1992.
57
   
The Guidelines to the Mental Health (Compulsory Assessment and Treatment) Act 1992 
(MH(CAT) Act), issued by the Ministry of Health in April 2000, sought to reinforce clinical 
recognition of the PAD directive by noting that the concept of “best interests” encompasses 
the requirement that a PAD must be considered in the determination of best interests.
58
  To 
mitigate legal uncertainty, it is suggested that preparation of an advance directive be made 
                                               
52 Health and Disability Commissioner (Code of Health and Disability Services Consumers’ Rights) Regulations 
1996. [Code of Rights]. 
53 Also see R Stent A Review of the Health and Disability Commissioner Act 1994 and Code of Rights for 
Consumers of Health and Disability Services: Review Document for Consultation. (Health and Disability 
Commissioner, Consultation Document, 1999) at 41. 
54 Pauline Wareham, Antoinette McCallin and Kate Diesfeld “Advance Directives: The New Zealand Context” 
(2005) 12(4) Nursing Ethics 349 at 351.   
55 S Johnson (ed) Health Care and the Law (3rd ed, Brookers Ltd, Wellington, 2004) at 102. 
56 At 102. 
57 Mental Health (Compulsory Assessment and Treatment) Act 1992, s 59. 
58 Karen O Poutasi Guidelines for Medical Practitioners Using Sections 110 and 110A of the Mental Health 
(Compulsory Assessment and Treatment) Act 1992 (Ministry of Health, Guidance Paper, April 2000). 
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with the involvement of family, a GP, and even a lawyer.
59
  In the New Zealand context, 
legal advice is helpful if the practitioner believes that there is strong family opposition to the 
contents of the AD and states “a valid AD must be made, without undue influence, by a 
competent person, who is fully informed about refusing the service in the future”.60  
An advance directive of any kind will be held to be valid if the following four considerations 
are met:
61
 
1) the consumer was competent to make decisions (when PAD was made); 
2) the consumer made decision free of undue influence; 
3) the consumer was sufficiently informed to make the decision; and 
4) the consumer intended the directive or choice to apply to the present circumstances. 
Alternatively, or in conjunction with a PAD, a patient may also establish an enduring power 
of attorney (EPA) under s 98 of the Protection of Personal and Property Rights Act 1988.  
The patient grants the attorney the power to make decisions on becoming incompetent and 
unable to make decisions.
62
. However, the proxy cannot refuse consent to standard medical 
treatment to save the person’s life.63 
It is at least arguable that, while New Zealand legislation does not specifically endorse 
advance directives, it nevertheless contemplates patients playing a role in deciding to some 
extent the nature of their treatment.
64
  Part 5 of the MH(CAT) Act presumes that a patient is 
competent to refuse treatment.  This is reflected in provisions such as s 58(4), which directs 
the responsible clinician to attempt to obtain the consent of the patient to any treatment even 
thought that treatment may be authorised by or under [the] Act without the patient’s consent. 
The presumption that a patient will be involved in deciding the nature of their treatment is 
also reflected in a number of the rights included in MH(CAT) Act in Part 6 (Rights of 
patients, particularly s 64 (General rights to information), s 66 (Rights to treatment), and s 67 
(Right to be informed about treatment).  But this presupposes that an individual has the 
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capacity to communicate their opinions and comprehend information about treatment at crisis 
point.  
C Scotland   
In comparison to New Zealand, Scotland’s comprehensive legislative coverage of PADs puts 
them at the other end of the legal spectrum.  The ground-breaking Mental Health (Care and 
Treatment)(Scotland) Act 2003 was enacted in reaction to the Millan Committee report,
65
 
which highlighted concern about the way people with disabilities were being treated under 
compulsory treatment orders.
66
  This Act gives patients the right to make and withdraw 
written statements that include information about how they would wish to be treated and how 
they would not wish to be treated, if they lose capacity to decide on treatment.
67
   
The Act requires the Mental Health Tribunal, persons authorised to give medical treatment 
under the Act, and designated medical practitioners,
68
 to have regard to the wishes expressed 
in ADs.
69
  If such persons, tribunals or treating medical practitioner make a decision that 
conflicts with the PAD, they are required to provide a statement in writing that sets out the 
reasons why a conflicting decision has been made.
70
  The decision must be communicated to 
guardians and advocates, a copy placed on the patient’s medical record, and reported to the 
Mental Welfare Commission for Scotland.
71
 
Other processes intended to enhance the ability of people with mental illness to participate 
fully include:
72
 
 consider the view of patient’s “named” person, carers, guardians, and welfare 
attorneys;
73
 
 the importance of patient participation as fully as possible in all decisions;74 
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 the importance of providing such information and support to the patient as is 
necessary to enable the patient to participate;
75
 
 the importance of providing the maximum benefit to the patient;76 
 the need to ensure that, unless it can be shown that it is justified in the circumstances, 
the patient is not treated in a way that is less favourable than the way in which a 
person who is not a patient might be treated in a comparable situation;
77
 and 
Considered in full, the Scottish mental health scheme seeks to address the communicative 
barriers that limit the opportunity of people living with mental illness to receive appropriate 
mental health care.
78
  In doing so, the scheme maximises the participation of persons in the 
medical decisions that affect them.
79
 
D United States  
Long before Scotland passed their PAD legislation, the United States pioneered the concept 
of an Advance Directive strategy.  The introduction of the federal Patient Self Determination 
Act 1991 (PSDA), subsequently passed by over 25 states, led to widespread recognition of 
PADs in state legislation.
80
 The Act requires that patients admitted to federally funded 
hospitals be informed about their right under state law to prepare an advance directive. The 
hospital is obliged to inquire and document whether the patient has executed an AD, to 
respect the documentation, and to educate health care providers regarding its use.
81
  Common 
to all of these statutes are limitations that allow for PADs to be overridden by mental health 
professionals without incurring civil liability, where failing to comply with the PAD breaches 
a duty of care owed by mental health professionals to the patient or to the third parties.
82
 
Further, these statutes do not allow patients to use PADs to avoid emergency involuntary 
detention.
83
 
The United States Living Wills Registry provides a good example of a national initiative 
which “electronically stores advance directives, and makes them available to health care 
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providers 24 hours per day via secure Internet or telephone-facsimile”.84  This registry has 
significantly improved the accessibility of PADs by mental health care providers during 
crises or emergencies where patients do not carry a card on them. 
Moreover, the National Resource Centre on Psychiatric Advance Directives is an online 
database that provides detailed information about the state laws.
85
  This comprehensive 
database, which is spearheaded by leading United States PAD experts and academics,
86
 aims 
to educate citizens about the law in their state and empower individuals and their support 
networks to charge of their own health planning. 
E Australian Debates 
Over the last 5 years, the Australian psychiatric community has pushed for recognition of 
PADs in Australian law.
87
  The Australian Human Rights Commission investigated the issue 
of living wills as applied to human rights of persons with mental disabilities almost 10 years 
ago, citing that PADs in mental health “participation and consultation are cornerstones of the 
National Mental Health Strategy”.88  However, very little action has been taken, despite HRC 
recommended that “psychiatric living wills [to be] formally recognised and registered by a 
Guardian Board or Mental Health Review Tribunal”.89 
The Australian Capital Territory has been the only Australian jurisdiction to give serious 
consideration to legislating for PADs by giving competent persons the right to consent to or 
refuse future medical treatment through “health directives” and/or appointed health care 
proxies.  A review of the Mental Treatment (Treatment and Care) Act 1994 (ACT)
90
 has 
specifically considered whether the legal recognition of PADs is necessary as part of its 
overall human rights-based reform of the Act.
91
  The major suggestion is that recognition and 
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guidance to ADs and PADs be brought under one unifying Act.  The legislative discourse 
continues in mental health circles today.
92
 
 
F  United Nations Convention on the Rights of Persons with Disabilities 
 
New Zealand ratified
93
 the United Nations’ Convention on the Rights of Persons with 
Disabilities
94
 in 2008 (CRPD).  The CRPD clarifies the obligations on State Parties to 
promote and ensure the rights of persons with disabilities and sets out the steps that should be 
taken to ensure equality of treatment.
95
  It goes into much more detail than previous general 
human rights conventions and the non-legally binding Principles for the Protection of Persons 
with Mental Illness and the Improvement of Health Care,
96
 concerning what action needs to 
be taken to prohibit discrimination.   
The CRPD is clear that State Parties must recognise that persons with disabilities enjoy legal 
capacity on an equal basis with others in aspects of life.
 97
  This means looking at the decision 
making supports people might need to be able to exercise this right.
 98
  Mental health advance 
directives can be seen as one of the avenues of supporting optimal decision making.
99
   The 
promulgation of the CRPD calls for a closer engagement with disability rights as they are 
expressed in international human rights law.
100
   
The CRPD provides a framework that encourages a new approach to mental health advance 
directives.  As a tool for the realisation of positive entitlements in mental health care, there 
are three key observations that flow from the human rights analysis of PADs.  These are that 
the CRPD privileges the perspectives of people with mental health conditions in all 
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matters;
101
 encourages approaches to the adjudication of human rights that adopt principles of 
proportionality;
102
 and supports the use of mental health advance directives as a human rights 
tool.
103
  A fuller discussion of how PADs can help New Zealand achieve compliance with the 
CRPD is beyond the scope of this paper, but there has been increasing interest in this area of 
analysis in international literature.
104
   
G Conclusions 
When compared to international jurisdictions, the New Zealand ‘law’ and policy on the 
formation, monitoring and enforcement of PADs is very weak and leaves much discretion to 
clinician and patients. Despite the call within the New Zealand medical profession to have 
clear, and nationally consistent guidance for PADs,
105
 this has not yet to be achieved.   
 
V  Content and Form of PADs  
Where advance directives in mental health have been introduced, concerns have been 
expressed by clinicians and others about the content of advance statements, including 
inappropriate treatment choices, ambiguity, or the impact of such decisions on resources.
106
  
A frequently expressed concern is that patients will refuse all treatment in a PAD, and the 
impact this will have on resources.
107
  However, research in both the United States and 
England suggests that it is very uncommon for people to refuse all medication.
108
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A number of factors might influence the content of a treatment PAD.  The law differs in 
different jurisdictions as to what content PADs should specify.
109
  The content and form of 
PADs can trigger legal issues which question the validity, revocability, and enforceability of 
these documents.  The limited New Zealand guidelines on content are ill-equipped to help 
clinicians, patients and support people to address these issues.  This section will first discuss 
the different models of PADs, then make suggestions about the type of content which create 
problems in practice.  It is concluded that what treatments people choose to write down is 
largely individualistic, and therefore can vary greatly.  
A Models of PADs 
PADs allow the person either to refuse treatment (proscriptive) or agree to treatment 
(prescriptive) or a mixture of both.  In the latter case, for example, a person may refuse some 
medication but agree to take another.  For example, they may refuse depot injections but 
agree to oral medications.
110
   
One question is whether advance acceptance of treatment is the same type of consent as 
advance refusal of treatment, or whether the two types of decision are qualitatively different. 
It is recognised that, while there is a right to refuse treatment,
111
 and an entitlement to 
medical treatment where appropriate,
112
 there is no entitlement to demand specific treatment. 
Part of the concern will have to do with the relationship of the advance, competent decision 
with the current, incompetent decision.   
But as compulsory, or mandated, treatment in the community becomes a more common 
option
113
 the possibility of using an opt-in advance directive to avoid compulsory treatment 
may increase.  Patients may be persuaded that being treated under an opt-in advance directive 
(and thus being voluntarily treated) is ‘better’ (less stigmatising) than being treated 
involuntarily.
114
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1 Ulysses clauses and the Self-binding problem 
Ulysses clauses are a type of opt-in treatment usually discussed in the context of strong 
models of PADs.
115
  Ulysses clauses have one controversial aspect: they are intended to be 
irrevocable by the patient.  People who have a tendency to refuse treatment as they become 
unwell may want to ensure that they are able to receive services under a Ulysses clause, even 
if they are not detained.  Whether clinicians can be bound by a Ulysses clause in a PAD, even 
against the contemporaneous wishes of the patient to revoke, has been widely debated.
116
  
This issue has been debated most in the United States under the Patient Self-Determination 
Act (PSDA).
117
  In the case of Hargrave v Vermont, the second circuit court held that the 
state of Vermont could not discriminate against individuals with psychiatric disabilities by 
preventing them from making binding preferences in a PAD regarding their treatment if they 
become incapable in the future.
 118  
Hargrave suggested that some Courts in the United States 
may uphold the irrevocable nature of a PAD as a valid and binding document.
119
  In many of 
the United States templates, individuals have a choice in making their PAD revocable or 
irrevocable when completing the document
120
 and can declare that it be revoked, suspended, 
or terminated if the governing law permits them to do so.
121
     
While Ulysses clauses may be enforceable in New Zealand, they are not binding against the 
clinician. Indeed, there is no right to demand treatment and PADs can always be overridden 
by the Mental Health (Compulsory Assessment and Treatment) Act 1992.  Arguably, Ulysses 
should not be binding against the individual.  Completing an advance directive does not 
necessarily mean that a person’s decision at one point in time (when mental capacity is clear) 
is necessarily more important than at a subsequent point in time (during a crisis period).
122
  
However, if an individual’s past values have been recorded, along with the reasons why the 
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advance directive was completed, it is easier to see how present wishes will correspond with 
future goals.
123
   
B Treatment and Non-treatment instructions 
In this paper, the term ‘treatment’ is used to include the act of administering medication as 
well as place and method of medical performance.  However, non-treatment specific 
directives are popular in the United States and Scotland, and non-treatment requests appear in 
advance care planning programmes in New Zealand.  In a 2007 Scottish study of the content 
of personal statements,
124
 almost 55% of all statements included some information about non-
treatment preferences.
125
   
These examples specifically detailed past histories of mental health problems and how these 
had been treated successfully.
126
  They included information on, for example, having access 
to the open air which had previously helped when experiencing ‘visions’, or information on 
personal leisure interests – such as reading and choice of music – that an individual wanted 
staff to be aware of.
127
  Some request that staff should keep hold of a person’s mobile 
phone,
128
 or contact family members to deal with person’s finances or childcare.129   
A key question is how useful a PAD which allows a wider range of information to be 
included.  Firstly, it may be difficult to see whom it will be enforceable against (an individual 
or the hospital ward), and puts undue strain on mental health professionals executing them.  It 
may help staff – especially those outside of acute care – have a better understanding of the 
person’s overall wishes and content for treatment, but it may also make upholding the 
advance statement more problematic for the clinician or at a tribunal hearing.
130
  The 
inclusion of non-treatment preferences appear better placed in wellness plans such as WRAP 
forms.
131
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C Key limitations with PAD content. 
In order for treatment preferences to be valid, they must remain within the boundaries of 
reasonable medical care.
132
  The medical community determines what constitutes reasonable 
care based on commonly accepted clinical practice, so that if patients record unreasonable 
treatment preferences in their PADs, clinicians will likely not be expected to honour such 
choices.
133
 
Other content issues which may lead to PADs not being enforced include: 
 ambiguous terms/ non-treatment terms; 
 terms which do not cover the patient’s particular situation; 
 no access to the treatment specified or the costs of using that treatment impacts in 
light of resource constraints.  
A clinician must be able to see that the individual has considered the implications of refusing 
or accepting treatments.  During the process of completing a PAD, it is useful for individuals 
to think about, and record their values and expectations affecting their current views of future 
medical treatment.   
D  Form of PADs 
As previously mentioned, the form of the PAD will ultimately influence the detail and length 
of content.  When discussing the ‘form’ of PADs, this extends beyond simply the layout of 
information as a document. It encompasses ‘housekeeping’ procedure including the use of 
witnesses and formal assessment of capacity.    
PAD forms vary from different clinics, even within the same jurisdiction.  There is no 
nationally consistent PAD form in mental health services.  However, the New Zealand 
Medical Association has an exemplar template for general (rather than mental health) 
advance directives
134
 and the Health and Disability Commissioner has a short exemplar for 
‘sentence structure’ purposes in their brochure on PADs.135  
Although the particular PAD form is not the determinative of validity, studies have shown 
that differences in forms have an influence in length and content that feature in PADs.  Reilly 
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and Atkinson’s 2010 study on the content of 55 advance statements in Scotland136 found that 
the format of the statement were not consistent and did not always conform to the templates 
suggested by the Scottish Executive.
137
  This inconsistency in the form meant that there were 
considerable differences in the content of the statement, from a simple single page in which 
consisted of “I do not want ECT” to three or four page documents outlining a wider variety of 
medical and personal issues.
138
 
Requiring a strict form to be followed may put off patients from completing PADs if they see 
rigidity of form as an added barrier.
139
  However, having a standard form which specify 
standard questions may be helpful for those who have never made an PAD, by prompting 
patients and whānau to consider and document specific information which aids PAD 
enforcement.  It is important to have sufficient information in the PAD for any enforcing 
clinician to determine whether the person had capacity at formation, whether the PAD was 
intended to cover the current scenario, and whether the patient understood consequences of 
their choices. 
Clinicians should not refuse to consider a PAD simply because it does not accord to a 
standard form. But the form goes towards influencing the content in the PAD, which itself 
may not be enough information answer an enforcing clinician’s questions.  
 
VI  Attitudes towards PADS – a New Zealand perspective  
A Methodology 
A small number of experienced mental health workers from various organisations within the 
Wellington Region were interviewed between August and September 2013.  Seven people 
were interviewed in total: four were practising psychiatrists and three were consumer 
advocates.  All had experience making or enforcing PADs.  Three had mental health 
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experience in overseas jurisdictions.
140
  Each interview was conducted using list of 27 
prepared questions.
141
    
The aim of the interviews was to gather qualitative analysis of some attitudes of service 
providers (and by their account, attitudes of patients) on PADs in the New Zealand context.  
It also confirmed many of the findings in PAD literature from other jurisdictions.   
Interviews were deliberately conducted with these two groups of mental health workers, from 
two ends of the service spectrum; clinicians administer and prescribe treatment while mental 
health consumer advocates received patient feedback.  This has highlighted some key 
differences in opinion on the purpose and normative legal standing of PADs.   
B Results 
1 General attitudes towards PADs 
All participants were very positive about the use of PADs where appropriate.  Clinicians 
considered PADs to be useful information sharing tools, especially when they are written to 
identify specific preferences.  It was acknowledged by all that clinicians exercising good 
practice would theoretically set aside their professional beliefs when addressing a well-
reasoned PAD, made by a competent patient.  However, in practice, a clinician’s decision is 
usually coloured by their own beliefs and values. 
Indeed, on the other end of the spectrum, there is still a negative perception of PADs amongst 
some practitioners.  These doctors, participants say, did not feel bound to work “under” 
PADs, and simply refused to consider them.  Clinical apprehension towards PADs was 
mostly borne by the concern that PADs contain insufficient information, or that they are 
poorly written and do not take heed of consequences of making a treatment decision.   
Clinicians interviewed mentioned that, in their experience, patients being introduced to PADs 
were generally receptive, but had little grasp of the time management and detail required.   
There was concern that, without guidance of whānau or a mental health worker, a patient 
trying to make a PAD alone may be put off by extensive information required.   
Advocates were supportive of PADs in theory.  Their experience listening to patient concerns 
showed that, in most cases, doctors did their best to consider the individual’s views.  
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However, advocates noted that the patients that perceived PADs to be futile were informed 
by stories of the negative experiences of other people, where competently formed PADs were 
ignored by the clinician or ‘trumped’ by the MH(CAT) Act.  Many patients did not know of 
their right to redress if their PADs were unfairly overridden.    
2 Benefits and costs of PADs 
All participants saw the benefit of PADs as a method of information sharing.  Two noted that 
PADs may clarify what the individual wants for themselves, which can be helpful when there 
are disputes between family members and there is conflicting discussion about what is in the 
best interest of this person who has now lost capacity.  PADs were seen as the clearest form 
of the intention of the individual. One participant noted the humanising effect of going 
through the process of understanding a PAD.  Clinicians are able to understand a patient’s 
previous experiences (be it positive or negative) as told by the patient themselves.  
In some cases, PADs were created as a protection tool for patients who have had a negative 
experience in the mental health care system.  Advocates emphasised that it is difficult to 
know how it feels to lose certain fundamental rights when subject to compulsory care.  One 
participant stated:  
Unless you have had that kind of experience, where you lose the right to make decisions about yourself, 
you kind of feel that your AD is your only safeguard against unbridled power. 
The fear amongst patients is that administration of treatment, and the extent to which a 
clinician will actually listen to their wishes, is totally dependent on that doctor’s attitudes 
towards.  Therefore, some believe PADs have the power to solidify and express to clinicians 
their express wishes, even if they are unable to fully communicate when ill. 
Clinicians identified that the major cost of promoting PADs would be the time and resource 
that goes into creating a well-reasoned PAD with sufficient context. One participant noted: 
Translating the quality of discussion into an AD is difficult and can be time consuming…very few 
doctors have the ability to spend time working that through.  Perhaps doctors should not be the first port 
of call. 
It was noted it would be inappropriate to recommend PADs to all patients.  Many have a 
good relationship with their clinician, and will have a continuity of care with that clinician. 
PADs may do little to assist these patients, who are assured that the current clinician knows 
of their treatment preferences. 
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3 Content and form of PADs 
Participants noted that the content of PADs are very personal, and will vary between different 
patients. Nevertheless, the list of common content listed by all participants include: 
 short biography of values and expectations; 
 signs that indicate the person is unwell; 
 the point at which the PAD should come into force; 
 treatment recommendation list (prescription and dosage) and supporting reason(s); 
 treatment avoidance list and supporting reason(s); 
 signature of witnessing clinician or lawyer; 
 signature of the patient; 
 date for PAD review. 
Five clinicians clearly understood the difference between a treatment PAD and a wellness 
recovery action plan (WRAP);
142
 the former specifies treatments needs and is usually used in 
crisis situations and the latter specifies general descriptors or wellbeing, to ensure long term 
good health.
143
 It was noted however that information such as early warning signs and 
triggers could feature on both forms.  These clinicians clearly saw them there being synergies 
in the way PADs and WRAP plans could work with each other.   
Interestingly, none of the participants knew whether their DHB or organisation had a pre-
made form.  Some participants thought that having some nationally endorsed prescribed 
forms would be helpful to guide the individual in the type of content they should include.  
One participant was apprehensive towards strictly applying a form, and what that would 
mean if an individual made a PAD outside the strict bounds of the prescribed form.  It was 
clear there was no consistent PAD form or strategy within the Wellington Region 
4 Promoting and forming PADs 
All participants noted that consumer advocates, community mental health services, and peer 
support networks were the most common points in the mental health system from which 
service users were introduced to PADs.  Most often this is when the individual has left acute 
services, and ready to plan for future events.  This suggests that, despite concerns of undue 
strain on clinical time spent helping patients make PADs, community workers and peer 
                                               
142 See Appendix 5. 
143
 See Appendix 4. 
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support by people with lived experience are more likely take up the burden of explaining the 
concept of PADs.  Indeed, it was implied that few practising clinicians would actively 
recommend PADs. 
The question, “who should be involved in the creation of PADs?” caused the most variation 
in answers.  Participants unanimously agreed that the support person(s) had two key roles: 
first, to help the individual give reasoned answers, and secondly to attest to that person’s 
competency at PAD formation. It is vital that this person is supporting with a therapeutic, 
rather than adversarial, perspective. 
The list of appropriate supporting people mentioned included: 
1) a clinician with sufficient knowledge about mental health treatment; 
2) the individual’s case worker if that is application; 
3) someone outside the mental health system, who is able to attest to general capacity; 
4) the patient’s general practitioner.  This person is likely to understand patient wellness 
as a whole and not just their mental state; 
5) whānau and close friends should at least be informed about the PAD or given a copy.    
Two clinicians agreed that it was not necessary to have a medical professional involved in 
PAD formation.  They believed that the procedural fairness and medical rationale can be 
exercised by the individual with a trusted other person.  However, the other five participants 
suggested that, to maximise the chance of having a PAD followed, it is best to have a medical 
professional (preferably a psychiatrist) to witness the PAD and attest to the patient’s capacity.   
None of the participants thought it was necessary for lawyers to be involved.  One person 
mentioned that legal professionals could potentially shift the PAD into a contractual 
paradigm.  This person warned against bringing a PAD outside of the therapeutic sphere:   
It is where the law is inquisitorial as opposed to being adversarial.  If you put together an AD that is 
adversarial, you’ve lost faith in your carers as being caring. 
All participants noted that it was important to encourage patients to not view PADs as an 
adversarial document that hinders conversation with practitioners. 
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5 Monitoring PADs 
This area was not substantially discussed, but one suggestion was to have a mail alert system 
similar to periodic GP check-ups alerts.  Provided that a copy of the PAD is kept at a 
patient’s most frequented practice, a reminder can be sent out every year for a PAD re-
evaluation.  The individual is able to review their PAD, make amendments, and redistribute 
the copies after witnessing.  However, using this method, the cost of notification is borne on 
by the mental health system. 
6 PAD enforcement 
One main issue for clinical enforcement of PAD is access.  Two clinicians admitted that they 
have retrospectively administered corrective treatment when it was not known at first 
instance that the individual had a PAD.  To address this, two participants suggested that a 
‘yellow note’ be placed the top of a patient’s file alerting clinicians that an advance directive 
exists, and that a copy of the PAD be filed under the individual’s national health index 
number.    
The suggestion of creating a centralised database full of registered ADs was put to all 
participants.  Clinicians were sceptical, saying that “yet another source of information 
storage” would be met with clinical resistance.  Comparatively, consumer advocates and 
support workers were very adamant that a database would work and through time, collect 
useful information about the numbers of directives, and the types of information lodged. 
The second enforcement issue clinicians mentioned was determining whether the person 
made the PAD with a competent mind.  Moreover, two participants noted that, while an 
individual may lose capacity under the Act, they may, in reality, have the capacity to make 
decisions in crisis situations.  One advocate noted: 
Even though [the patient] knows exactly what they need to feel better and they communicate this with 
doctors, some doctors just want to give you the flavour of the day [medicine]…the “atypicals”.   
Each clinician was asked in what circumstances a PAD could be overridden.  Major 
consideration included whether the individual poses a significant harm to themselves or 
others.  It was noted that ‘harm’ was a relatively high threshold, and would include the risk of 
violence.  
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Some asked whether partial fulfilment – or adherence to the spirit – of the PAD is sufficient 
to constitute ‘enforcement’.  Depending on the specificity of the PAD, partial fulfilment may 
be justified, especially when the PAD is difficult to follow and the clinician is doing their 
best to comply with the patient’s requests.  
Three participants suggested there should be a ‘third party PAD facilitator’ to guide clinicians 
in their decision, and to document the doctor’s rationale for an enforcement decision.  The 
facilitator would be involved when a clinician needed a second opinion to overturn an 
advance directive.  They would also be responsible for collating these reports, and in time, 
develop an expertise about dealing with PADs in medical practice. 
7 Strengthening the frameworks around PADs 
While all clinicians supported the further promotion of PADs, two were against any 
legislative fortification of PADs.  Instead, better support should be given to NGOs and peer 
support networks to educate individuals and their whānau about the use of PADs.  All 
clinicians agreed that any legislative reform should still give clinicians the flexibility to make 
medical decisions in light of the circumstances at hand.   
Consumer advocates (and presumably patients) overwhelmingly supported the strengthening 
of frameworks around PADs.  Four participants suggested that PADs be “embedded in the 
MHA legislation” to give it a stronger legal status, although the finer details about how this 
could be achieved were not discussed.  They cited two reasons: to demonstrate to patients that 
it is not as easy to override, and send the message to clinicians that PADs should not be 
lightly dismissed.   
The participants who supported the third party PAD facilitator suggested an inclusion of a 
clause in the PAD: that “any departure from the AD has to have discussion and sign off by 
district PAD facilitators”. 
C Limitations and further research 
One key party who is missing from this dialogue is the perspective of the mental health 
patient themselves.  Due to limited time and resources, interviewing patients was not possible 
in this study.
144
  This problem has been partly mitigated by getting the perspective of 
                                               
144 An Auckland University School of Nursing research team is currently conducting quantitative research on 
the attitudes of service providers and service users towards PADs.  Initial findings to come out as soon as 
November 2013. 
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consumer advocates.  Consumer advocates who gather service feedback from patients can 
shed light on the quality of services from the patient’s perspective.  
Another limitation of this study is the regional scope.  All but one of the participants 
practised in Wellington, under Wellington CCDHB.  Therefore, concerns (or perhaps lack of 
concern) over aspects of practice may be a region-specific issue.   
 
VII  PAD formation  
Part VI highlighted key legal and practical area in PAD formation that should be clarified for 
good practice in the New Zealand context. The first is ensuring that the individual has the 
capacity to make a PAD, and who is the best person to attest to capacity at formation.  The 
second is to identify the role of support people; who should educate the individual about the 
PAD, who should help prepare it, and whether there is a need for witnesses.  These two issues 
are interrelated.  The question of who is best at determining capacity will be a major 
consideration in recommending roles for service providers and other support networks.  The 
challenge for clinicians and family members is to refrain from declaring the persons 
incompetent to make a PAD simply because they have reached a different, and perhaps a bad, 
decision.
145
 
A The Issue of Capacity to Execute 
A person who chooses to make a PAD must have the requisite capacity to make a decision 
about their mental health treatment.
146
  There was once a widespread assumption that if 
people were mentally ill (and especially if they were detained by reason of a mental disorder) 
there was no question of their having the capacity to consent (or refuse consent) to 
treatment.
147
  This is no longer correct.
148
 In New Zealand, the vast majority of treatment of 
mental illness, broadly defined, is on the basis of the patient’s consent. 
                                               
145 Dunlap, above n 45, at 367.  
146 Code of Rights, above n 52, cl 4; Srebnik and Brodoff, above n 7, at 257. 
147 Skegg and Paterson, above n 62, at [6.2.1]. 
148 In Re S [1992] 1 NZLR 363 at 374; Re C (Adult: Refusal of Treatment) [1994] 1 WLR 290 [1994] 1 All ER 
819 (Fam D). 
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Capacity is a common law requirement.  It is a necessary predicate for the valid execution of 
many legal transactions from wills to contracts to marriage.
149
  It is also an aspect of 
“informed consent” for treatment or refusal thereof.150   
There is no all-purpose test of capacity to give or refuse consent to medical treatment.
151
  
Even in specific context of medical procedures, the courts have not adopted one test to the 
exclusion of all others.
152
  
Most tests, however, have three main elements.
153
  To be competent, a person must have the 
ability to: 1) communicate a choice; 2) understand relevant information; and 3) appreciate the 
situation and its likely consequences.
154
  Often making a PAD with a clinician may help the 
individual to demonstrate (2) and (3).  Making it with whānau can help the patient better 
communicate these wishes.  For completion of PADs, these abilities should be shown within 
two decision making areas: creating the directive itself and the substantive treatment choices 
specified within the document.
155
   
Re T (Adult: Refusal of Treatment)
156
 concerned a Jehovah’s witness who refused blood 
products, and provides comments about the capacity to consent which is helpful in this 
context.  Lord Donaldson delivered the leading judgment, in the course of which he said:
157
 
Doctors faced with a refusal of consent have to give very careful and detailed consideration to the 
patient’s capacity to decide at the time when the decision was made.  It may not be the simple case of the 
patient having no capacity because, for example, at that time he had hallucinations.  It may be the more 
difficult case of a temporarily reduced capacity at the time when his decision was made.  What matters is 
that the doctors should consider whether at the time he had a capacity which was commensurate with the 
gravity of the decision which he purported to make.  The More serious the decision, the greater the 
capacity required   
At the end of his judgment, Lord Donaldson MR provided a helpful summary, which 
included the following passage:
158
 
                                               
149 Skegg and Paterson, above n 62, at [6.2.1]. 
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Doctors faced with a refusal of consent have to give very careful and detailed consideration to what was 
the patient’s capacity to decide at the time when the decision was made.  It may not be a case of capacity 
or no capacity.  It may be a case of reduced capacity.  What matters is whether at the time the patient’s 
capacity was reduced below the levels needed in the case of a refusal of the importance, for refusals can 
vary in importance. 
This passage acknowledges that there can be levels of capacity, and the potential to have 
reduced capacity but not lose it entirely.  The provision in the Consumer Code of Rights is 
consistent with Lord Donaldson MR’s view that capacity is not an all or nothing matter.  
Right 7(3) provides that where a consumer has diminished competency, that consumer retains 
the right to make informed choices and give informed consent, to the extent appropriate to his 
or her level of competence.   
The capacity required will change with the gravity of the situation.  In the case of advance 
directives for end of life situations, the refusal of treatment can have serious and irreversible 
consequences (usually the advancement of death).  Therefore a high level of competence is 
required to fully appreciate the consequences.
159
  By comparison, the consequences of refusal 
or acceptance of treatment in mental health may not have such an immediate and serious 
consequence because there is scope for the individual to get better.
160
  Usually refusal of 
treatment is very specific – identifying particular medications that the person would not want.  
The converse may be true, if the individual refuses the lynchpin treatment which will put the 
individual in a position to recover.  For example, a person suffering from anorexia who 
makes a PAD refusing future treatment involving force feeding could in fact die if her PAD is 
adhered to.  In such cases, capacity must be measured against this more serious consequence.   
Some feel concern that the level of competency required to form PADs are “overblown”161 
and it should be noted that many physical illnesses (e.g. multiple sclerosis, AIDs, dementia) 
may affect cognitive capacity in ways similar to mental illness.
162
  Advocates note that it is 
important not to create a different standard of competency for mental health consumers from 
others attempting to create health care ADs.
163
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 At 116. 
159 Dunlap, above n 45, at 368. 
160 Papageorgiou and others, above n 22, at 385. 
161 Dunlap, above n 45, at 327. 
162 Okai and others “Mental Capacity in Psychiatric Patients: Systemic Review?” (2007) 191 The British Journal 
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Because often the question of competency and insight into the consequences of treatment is 
not a clear-cut issue and the inquiry is after the fact (of PAD formation), it is important to 
have people who can verify the competency of the individual at the time of formation.  
However, as the current practice stands, the parties attesting to a person’s competency are not 
always medical professionals nor legal professionals, and this may cause evidentiary and 
legitimacy issues. 
B Parties to be Involved in PAD Execution 
1 Clinicians and Service Providers 
Clinical advice given at the time the patient completes a PAD has benefits and disadvantages.  
On the one hand, it is important that consumers have sufficient information about health care 
treatments when they executed the PADs.
164
  The fear is that a patient might not be fully 
informed about treatment options, particularly if PADs are completed outside of a clinical 
context.  This may lead to more unreasonable requests.  Mental health service provider input 
will better ensure that individuals understand the full consequences (or clinical result) of their 
decision, and still keeping within the realms of good practice.  Service providers may be able 
to anticipate additional medical circumstances for prior planning that a patient themselves 
may not think of otherwise.  
The importance of clinical involvement in formation is evident in literature and the 
interviews conducted for this paper.  Some clinicians would not apply a PAD unless the 
individual has had consultation with a service provider.
165
 In a United States PAD survey, 
92% of clinicians reported that it would be “somewhat”, “very”, or “extremely” useful to 
have service providers help consumers execute the PAD.
166
  In the interviews conducted with 
New Zealand clinicians in this paper, five of the seven participants agreed that clinical 
involvement would maximise the chance of having a PAD enforced.
167
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On the other hand, a contentious question is the level of involvement service providers should 
have in PAD formation.  There is a concern that clinicians might unduly influence the process 
or undermine consumer choice.
168
   
Whether it should always be necessary to have patients create advance directives with 
clinicians, and if so, what role within the formation process are harder questions to answer.   
Psychiatrists in particular have expressed a reluctance to spend significant time constructing 
PADs with consumers in a public health system, where their valuable time should be spread 
fairly amongst treating other patients for more urgent matters.
169
   
In the United States, the Patient Self Determination Act requires that patients admitted to 
federally funded hospitals be informed about their right under state law to prepare an advance 
directive.
170
  But, to put the same onus on service providers to explain the workings of a PAD 
to every patient who is admitted to public hospitals in New Zealand is neither practical nor a 
good use of service provider time.  
2 Consumer Advocates and Peer Support Networks  
Despite the potential advantage of clinician involvement in legitimising the PAD, an 
interesting finding from the interviews conducted for this paper is that many service users 
created PADs at the instigation and in collaboration with consumer advocates and peer 
support networks, rather than clinicians.
171
  
Consumer advocates work for regional DHBs, advising patients of their rights, listening to 
their needs and provide consumer feedback to DHB planning.
172
  There are also an array of 
mental health support services outside of inpatient care, that cater to supporting individuals 
and their families in the community with mental health care planning.
173
  Additionally, peer 
support services in mental health involve networks of people who have experienced similar 
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adversity, who provide advice to other service users to plan before crisis, for sustained 
wellbeing.
174
 
Axiomatically, these three groups of people are better poised than clinician to promote PADs 
to patients.  They tend to have more time to spend with mental health patients on the quality 
of their care.  While direct service providers may be strained by key performance indicators 
(including incentives to moving individuals to outpatient care), advocates’ main role is to 
better understand the patient’s needs and preferences and communicate these needs to better 
inform service providers.
175
  
Additionally, advocates and social workers have the ability to hear from a greater population 
of patients about quality of care, and identify general patterns in patient satisfaction.  They 
specialise in understanding the holistic needs of patients, not just the medically treat the 
outward manifestations.  Some patients simply do not feel comfortable criticising the 
practice of clinicians to their own clinician.
176
  Patients may feel more comfortable confiding 
in and discussing PAD content with advocates and social, because they are not required to 
treat the individual. 
Peer support networks are particularly influential on current service users.  Peers have lived 
through similar experiences and are trained to educate others.
177
  The advice to make a PAD 
and the rationale for doing so is more insightful coming from a person who can truly 
empathise with the patient’s experiences. This insight is heightened if the individual has had 
their PAD upheld in a positive experience, reinforcing the power PADs have in giving 
patient voice a platform to be heard.   
3 The Role of the Family and Whānau 
The other group of people who are most likely to understand a patient’s experience with 
mental health treatment is close family and whānau.  Family members are the most often 
quoted emergency contact, and can often see the signs of a person becoming unwell better 
than any clinician. 
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The HDC brochure on making mental health ADs recommends the involvement of family 
and whānau when preparing advance directives, or at least informing them of it so that they 
are better equipped to voice the individual’s wishes in a crisis.178  In many enquiries after a 
patient’s death or some alleged misconduct, it has been the evidence of whānau that attests to 
the patient’s capacity.  However, being reliant on family members to highlight the importance 
of a PAD is not always effective. There have been stories where parents of a mentally unwell 
patient who had an advance directive omitted to bring the PAD to the attention of the doctor, 
having presumed that the doctor had already read the PAD.
179
   
Whānau input may be particularly important for the therapeutic process of Māori mental 
health patients.  The Te Whare Tapa Whā, a model for understanding facets of Māori health, 
was developed by Professor Mason Durie recognises four components to Māori health, one of 
which is for whānau to play an important role in the wellbeing of a person.180  Whānau can 
contribute to sickness as well as assisting in curing illness.
181
  The sense of belonging and 
strength that whānau provide – especially in the acceptance and understanding of a person’s 
advance directive – is a key foundation of Māori health.182  This cooperative agreement may 
explicitly involve the specification of family members who may be contacted if the PAD is 
invoked, or if the PAD is changed with a clinician.
183
   
4 Witnessing PADs 
In the United States and Scottish jurisdictions, it is generally expected that an advance 
statement will be witnessed.  In New Zealand, a valid will must be witnessed by at least two 
people.
184
  In the medical context, the key question is whether the witness is attesting to the 
capacity of the person making the advance directive (and how formal this assessment is) or 
simply that the person made the advance directive themselves.
185
  
Where the witness is attesting to the capacity of the person, it is important that the said person 
has the requisite knowledge to recognise capacity.  The guidelines to the Scottish Act 
prescribes a list medical and legal professions deemed acceptable witnesses, including such 
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as doctors, nurses, solicitors, and social service worker.
186
  The position of the witness is 
described to the person making the advance statement as “…confirming that in their opinion 
you are able to understand what you have written in the statement and the effect it might have 
on your future treatment.”187   
Witnessing could be seen as a limited approach to attesting capacity.
188
  In the Scottish 
system, it is assumed that both medical and legal professionals are able to attest capacity, 
even though the two may apply tests with a different focus.
 189
 Without any consistent guide, 
the way that a clinician assessment competency could medical-centric, while a lawyer 
focuses on ability to understand their own decisions.
190
  Although the end result may not be 
different, the competency to execute test should be clarified in either guidelines or statute.   
The Scottish system clarifies that, while the witness must ensure the patient has considered 
their choices, that person does not have to be involved in writing of the advance directive.  
Nor does the person need to agree with the individual’s choice.191  These two points are likely 
to be important to patients as they emphasise the independent nature of the PAD.  The 
professional asked to witness a PAD should also feel more comfortable if the directive goes 
against what they would advise or see as best practice. 
C Conclusion 
In the New Zealand context, in light of both clinical concern whether PADs are made with 
sufficient patient awareness of consequences, as well as scepticism as to whether clinician’s 
time is best used to educate the patient about PADs, requiring that a clinician or social worker 
witness the advance directive for capacity seems a good half-way solution. Clinical 
agreement with the treatments specified need only extend to acknowledging that treatment is 
still within good medical practice, even though the clinician may not think it is the most 
effective treatment.  Taking away the conscience element widens the scope of potential 
clinicians who are able to witness.  A definition of ‘clinician’ should be made in legislation or 
formal guidelines.
192
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VIII  Storage and Monitoring PADs 
A Storage and access  
PAD which cannot be accessed at a crisis point, or which no one knows exists, is not worth 
the paper it is written on.
193
  Having PADs housed within after-hours services and outpatient 
medical records is to be a minimum required for accessibility. 
The complexities of accessing PADs in crises time are corroborated in literature, 
demonstrating that health care advance directives are accessed by staff in only about one third 
of cases.
194
  In a study of 161 service-users in the England, over half did not remember what 
had come of the PAD only a year after making it.
195
  A good access system should not rely on 
an ill patient to raise the existence of a PAD.  However, a patient is able to help ensure that 
their PAD is stored in places or with people that can raise it in a crisis.
196
 
1 Who should be informed? 
Scottish Advance Statement Guide provides a fairly extensive list of people to whom a copy 
of the AD should be given.  This covers, where they exist, a named person, carer, family, 
solicitor, nurse, independent advocate, guardian, welfare attorney, responsible medical 
officer, mental health officer, general practitioner, and other people close to you.
197
  The 
advantage of giving your PAD to an extensive list of people is that, the more people who 
have a copy, the easier it might be to access it when it is needed.
198
  Information privacy 
issues caused by a widespread dissemination may be avoided if whanau know where the PAD 
is kept rather than holding a copy at all times.
199
  
2 Electronic Health Records (EHR) 
An obvious place to indicate the existence of a PAD would be at the front of the patient’s 
medical records in the EHR, which prompts the clinician to read further into the individual’s 
medical notes.
200
  An enhancement of this feature would be if the computerised record not 
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only flags up an advance directive at the outset, but also requires confirmation that this had 
been noted.
201
  It could be amended to require consultation before hospitalisation or before 
compulsory measures are taken.   
However, a barrier to strengthening access to PAD highlighted in Part VI is the difficulty of 
inputting and removing information from the EHR system.  Currently only certain clinicians 
within the DHB system is able to add and remove information on patient’s NHI record.  
Furthermore, the clinical access between regional DHBs still causes problem as DHBs have 
different operating systems.
202
  Ideally, an EHR would be distributed across all health settings 
and be centred on the person, rather than being a series of isolated information repositories 
located within various health care agencies.
203
  In the current position, individual DHBs 
would have to be proactive in lodging PADs onto the register, or alternatively the Ministry of 
Health would have to make a big effort to centralise the access of information.
 204
 
B Reviewing and changing PADs 
While a PAD may represent the competent wishes of patient at one point in time, this is 
subject to a change of mind.
205
  A patient may have since been treated with more effective 
medication, their values and expectations have changed, or their physical health may have 
altered.
206
  All of these factors may mean that the PAD is no relevant to the patient in their 
current health.  Even if preferences have not changed, it is important for the acting clinician 
to be sure of this, especially if a clinician is put in a position where a decision has to be made 
about whether to follow a directive that was made some time ago.  Without frequent review, a 
clinician may be justified in overriding a PAD.  Any legislative or ‘good-practice’ guidance 
for making PADs should encourage individuals to review PADs and set a defined renewal 
date (for example, every five years).
207
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IX  Enforcement of PADs 
This section discusses some of the more difficult philo-ethical and legal issues surrounding 
PAD enforcement by service providers.  Again the issue of capacity is central to when a PAD 
is invoked. This can create a tension when there is subsequent express revocation, and the 
clinician’s moral and ethical judgements are tested.  A ‘good practice’ guideline will develop 
a transparent decision-making procedure for clinicians, that both service users’ and service 
providers’ trust, and can be applied consistently.  In doing so, legislators should understand 
that PADs are nested in larger structures of mental health law and policy that protect the 
interests of parties other than the patient.
208
 
A When is a PAD invoked? 
When to invoke or activate a PAD is not always a straightforward procedure.  In the eyes of 
the law, a person is presumed to have capacity unless legally declared otherwise,
209
 or unless 
good cause can be shown for presuming otherwise to allow, for example, emergency 
treatment.
210
  Thus, invoking a PAD necessarily means that a judgement about capacity has to 
be made.   
In New Zealand, the Code of Consumer Rights cl 4 states an advance directive is intended to 
be effective only when he or she is not competent.  In some jurisdictions, PADs are invoked 
when a person falls within the Mental Health Act (even though this is usually the same as 
saying someone lacks capacity to make treatment decisions).  In Scotland, for example, once 
a patient comes under the provisions of the Mental Health (Care and treatment) Scotland Act 
2003, account has to be taken of any existing advance statement.
211
  
The quandary about when to activate PADs raises a broader question about the purpose of 
PADs: are they used to help de-escalate crises and provide alternatives to outpatient 
commitment and hospitalisation, or are they to be implemented only under the limited 
circumstances of legal incompetency?
212
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Activation of PADs early in a mental health crisis can be invaluable to medical staff as a 
guide to appropriate and desired care.
213
  In this way, PADs would be used in the same 
manner as a crisis plan.
214
  Some advocates agree and would like PADs to be activated early 
enough to provide treatment to individuals who show signs of decompensation, but who 
nevertheless “fall through the cracks,” neither actively participating in voluntary treatment 
nor meeting criteria for involuntary treatment.
215
  If the aim of the PAD is to provide early 
treatment (which might be refused) to prevent or de-escalate a crisis, then the ‘loss of 
capacity’ threshold for invoking the PAD might be set lower.  
However, given the presumption of capacity to refuse treatment, a more formal capacity 
assessment should be made before a PAD is activated.  Many psychiatrists appear unwilling 
to declare a patient incapable unless detention, guardianship or similar circumstances exist.
216
 
This formal approach to invoking a PAD is likely to reduce their use, and this usefulness in 
promoting patient choice and autonomy 
This may be further complicated if the PAD covers more than just medical treatment.  
Patients may be impaired in making a decision about their clinical care, but capable of 
making other decisions.  Although this will only cause practical problems if decisions in the 
advance directive differ from current decisions, it cannot be optimal or in accordance with the 
least restrictive alternative, to be using the PAD where it is not necessary.
 217
  Yet to argue for 
only invoking parts of it is likely to be problematic.  
Any best practice guideline needs to give clinicians clear direction to determine when 
capacity is lost, and specify whether the capacity requirement is the same as that to execute a 
will.
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B  Should the PAD be followed by the clinician? 
When an advance directive is brought to the attention of a treating psychiatrist, there should 
be a positive obligation at the minimum to explore the reasons for such prior content 
wishes.
218
   
There is no gold standard of when it is acceptable to override a competent person’s wishes in 
an advance directive with impunity.
219
  Doctors are under no obligation to follow an advance 
directive to which they hold a conscientious objection or see the action as unethical.
220
  In 
such a circumstance, the doctor should explain to the medical team involved, and any pointed 
surrogate decision maker, why they are not willing to follow the PAD.
221
   
Brock
222
 has outlined three general types of scenarios in which clinicians might consider 
overriding a general ADs: 1) when there is doubt that the AD accurately reflects what the 
patient would have wanted, 2) when the moral authority of the advance directive is 
questionable due to concurrent revocation, and 3) when the interests of persons other than the 
patient warrant overriding the directive. The next section considers whether these scenarios 
may be proper justifications for overriding ADs in the psychiatric context. 
1 PAD reflect patient wishes? 
From the perspective of patients with a long history of psychiatric treatment, PADs convey 
treatment preferences much more accurately than medical ADs used in end of life situations, 
as it is often written in light of previous treatment experiences.  Rather, a more pressing 
problem for clinicians is when the PAD contains insufficient information to show that the 
person considered the particular circumstance at hand.
223
  This suggests the importance of a 
framework at formation which promotes the articulation of explanation for treatment 
decisions.
224
   
There have been doubts raised particularly in the case of patients who refused ECT in a PAD, 
but have never themselves experienced ECT.
225
  In the scenario where a patient falls into a 
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catatonic state from extreme depression (something the patient never expected to happen, 
even in a worst-case scenario),
226
 clinicians have been justified in treating the patient with 
ECT, where it is a last resort to save their life.  It presumes that a patient’s wishes would 
never be to die as a result of not receiving treatment.     
This issue can also be alleviated if there is enough general information about the patient’s 
values and expectations within the PAD, so that a clinician can try and uphold a patient’s 
treatment decisions wherever possible and if it is consistent with their stated values.
227
  In this 
case, the PAD stands as the best evidence of what the consumer would have chosen for 
treatment if competent.
228
 
2 Patient current revocation of a valid PAD 
A further complication for clinicians occurs if the patient, who is now ill and lacks requisite 
capacity, revokes what was specified in their PAD.  For example a person who suffers from 
anorexia may refuse to be force fed in an acute situation, even though her PAD has 
specifically agreed to force-feeding treatment in a crisis scenario.
229
 
Revocation is particularly problematic in areas of psychiatric treatment.  Cases of revocation 
of an AD which is enacted in general health care crises are rare because usually the person is 
unable to communicate, or may be out of consciousness altogether (in end-of-life scenarios).  
The ‘blurriness’ in the revocability of mental health advance directive at crisis point occurs 
partly because the power to make a PAD is implicit in the Code of Rights allowing the 
making of general advance directive.  In PAD revocation cases, whether to enforce treatment 
against a currently refusing patient who is incapable of revoking is difficult to determine.
230
 
The New Zealand law requires consumers to be competent or have capacity in order to make 
an advance directive. It is a fair inference to draw that competence again is needed to change 
an advance directive.
231
  However, doctors are uneasy about “enforcing” the preferences 
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specified in a PAD against the contemporaneous revocation of those preferences.
232
  Such 
enforcement could lead to coercion and uncooperative treatment.
233
  
(a) Revocation of an opt-out provision 
Where the person has opted out of certain treatment and then changes their mind, clinicians 
may be happy to accept this, possibly choosing to see it as the beginning of a return to 
capacity.
234
   In most cases clinicians are likely to follow patients’ choices where they opt for 
treatment and maintaining and preserving health and life than not. 
To draw a comparison, women with advance directive birth plans routinely change their 
minds during labour.  Birth plans made by pregnant women often request ‘natural child birth’ 
and no medication for pain.  However it is not uncommon for women to change their minds 
during labour and request pain relief.
235
  This is given, and to most people it would be 
inconceivable for the doctor or midwife to say to the woman “several months ago you said 
you didn’t want pain relief so you’re not getting it”.  It is despite the fact that everybody 
understands that pain has a clear impact on judgement and ability to make rational decisions. 
However, the legitimacy of a revocation might be questioned when it is not expressed as an 
active request but more in the form of an “I don’t care anymore” mentality to treatment, 
prevalent in patients worn down by illness and possible pressure from clinicians, family and 
friends.
236
   
(b) Revocation of an opt-in provision  
A more likely scenario is for the patient to revoke an opt-in provision.  Deciding whether to 
uphold the revocation is even more difficult.  There is concern that the revocation is a 
symptom of the mental illness, and is the exactly the reason for which the PAD was 
written.
237
 A Ulysses clause is an example where the individual specifically seeks to make 
their wishes irrevocable.
238
   
Consideration must be given to the reasons why the individual included the opt-in clause in 
the first place; a nuanced exercise.  If it was to self-bind, like a Ulysses clause, so as to 
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deliberately ignore the irrational behaviour when ill, then this seems to suggest that it would 
be in the best interest of the individual for doctors to adhere to the PAD against an express 
revocation.  If it was a general early opt-in for treatment to pre-empt worsening of the 
person’s mental state, then perhaps revocation should still be respected when the person loses 
capacity.  
Winick proposes that consumers should be able to choose whether they want a PAD that 
could be revoked at any time or only when not considered to be incapable.
239
  It has been 
suggested that they should also make a statement about whether they can revoke it at any 
time, or only when they are capable.
240
   
Others argue self-binding PADs could be worded in a way to require serious intervening 
factors before a doctor can override, including the significant risk of serious harm to self and 
others.
241
  This was certainly the view of Wellington clinicians interviewed, who believed an 
absolutely binding PAD may cause problems if it is not in line with good clinical care.
242
 
3 Protecting the interests of others 
Brock raises the quintessential example to demonstrate this dilemma: the interests of a patient 
near death have substantially diminished and interests of the family are the driving force in 
medical decision-making – a phenomenon colloquially known as “treating the family”.243  
For example a clinician may refused to apply an opt-in PAD in cases where the clinician 
believes this treatment will be psychologically futile, yet the patient and the family demands 
it.
244
   
An extension of this argument is one on the basis of distributive justice: that it is unfair to 
expend scarce medical resources on futile care for one patient merely because the patient 
requests such care in advance.
245
  The opponents of the court’s decision in Hargrave v 
Vermont have argued that, priority should have been given to the larger interests of society in 
this matter – for example, the interests of the taxpayer who might ultimately have to pay for 
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longer hospital stays for psychiatric patients with PADs that refuse antipsychotic 
medications.
246
 
While the interests of the family and other patients (indirectly through distribution of 
resources) must be taken into account when deciding whether to revoke a PAD, they should 
not be held as determinative factors for overriding PADs. It is important that we give 
clinicians the flexibility to balance factors and exercise their better professional judgement.  
X Key Recommendations   
A Legislative Amendments 
From the interview discussions in Part VI, it was clear that advocates and patients wanted the 
“legal standing” of PADs strengthened.  What this could mean has not been elucidated until 
now.  Any strengthening of legal standing must take heed of two issues.  Pertinently, 
clinicians make hard decisions on a day-to-day basis, and are personally accountable for the 
outcome.  Therefore, a doctor should be under no absolute legal obligation to follow an 
advance directive which is inconsistent with good medical practice.
247
  If absolute legal 
obligation is put into such a written document, a doctor may be forced to take responsibility 
for following a PAD against their better judgment.
248
   
Furthermore, it may not be possible for a clinician to follow an advance directive if certain 
circumstance that existed at the time the PAD was made has changed, or if the PAD is not 
worded in a way that considers the particular circumstance at hand.  Therefore, the legal 
structure must be able to give clinical flexibility to exercise good judgement.   
This is balanced with the policy of promoting patient participation, even if they are subject to 
compulsory treatment under the MH (CAT) Act.  As noted in Part VI,
249
 this is particularly 
important given that patient’s request (and the capacity to make requests) is questioned as 
soon as they are deemed “mentally disordered”250 and require treatment against their will. 
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1 Right to have PADs considered 
With the two tensions above in mind, it is proposed that a section requiring the consideration 
of PADs be included in the MH(CAT) Act 1992.  This could be achieved with an additional 
section to the ‘rights of patients’ under Part 6.251  Similar to the Scottish Model, this section 
would make it a right for all patients to have their wishes considered by the treating clinician, 
if attention is raised to the existence of an advanced directive.
252
  This right would apply for 
urgent emergency treatment as well as compulsory treatment orders.
253
  In addition, a 
clinician should be required to explain to the patient, as well as have in written record, the 
reasons for overriding a PAD.
254
   
Placement of this section under the MH(CAT) Act is important for two reasons.  Facially, it 
clarifies that ADs in the realm of mental health will be given validity.  Until now, validity has 
only been presumed under the provision for general medical advance directives in the Code 
of Rights.  Moreover, it recognises that, in most cases, a PAD would only come into force 
when a person loses capacity, and there is a need to administer compulsory treatment or 
certain emergency treatment.
255
  It addresses the misconceived opinion that clinicians do not 
need to consider PADs if a patient is under the MH(CAT) Act.
256
  
Substantially, the ‘right for PADs to be consideration’ strikes a balance between ensuring 
patient’s wishes are heard, but also allowing that clinicians the room to override the PAD 
when it is not in good practice to follow it.  The documentation requirements ensure that 
clinicians do not lightly override a patient’s will and think through alternatives, while 
simultaneously protecting clinicians who makes a sensible judgement call to give treatment to 
save the life of a patient.  Having sufficient records also ensures evidentiary transparency for 
the patient.     
Holistically, the inclusion of this right will serve as a catalyst – or a ‘top-down’ approach – to 
encourage DHB and external mental health services to develop a long-term PAD strategy.  If 
it is a patient right under the MH(CAT) Act, its consideration must be integrated into the 
practice of service providers.  This directly addresses the problem that it is not common 
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practice for clinicians to inquire whether a patient had a PAD when they first entered the 
DHB system.
257
   
2 Redress under the MH(CAT) Act 
If a patient believes that a clinician has disregarded their PAD without proper reason, there 
can be redress under the MH(CAT) Act.  This would be a separate form of redress, from what 
can already be addressed through the complaints process under the Health and Disability 
Commissioner Act 1994,
258
 and complaints under the Human Rights Commission.
259
  
3 External PAD facilitator 
Many of the clinicians interviewed under Part IV discussed the usefulness of having a PAD 
facilitator that specialised in the implementation of PADs in medical practice.  A facilitator 
would be employed by the DHB and have three key roles: to oversee the PAD process and 
give a second opinion if requested; to write up a report when a PAD is not followed; and to 
collect reports and synthesise patterns to develop clinical guidance.  In order to give a second 
opinion, the facilitator must himself be a clinician with mental health service experience.  
However, the decision to administer or not administer treatment against the wishes of a PAD 
would ultimately be made by the treating clinician. Given current resource strains, the 
creation of an external PAD facilitator would be a best case scenario.   
B Education and PAD Support Programme 
Legislating for the consideration of PADs by clinicians in a ‘top-down’ approach addresses 
issues of enforcement and access to an extent.  However, to achieve cultural and systemic 
change in the perception of PADs, this needs to be supplemented by a ‘bottom-up’ approach 
by providing education and guidelines to service providers and service users.   
1 Guidance for clinicians and legal professionals 
The Ministry of Health should supplement the legislative amendments with a ‘good practice’ 
guideline.  This should be specifically targeted at clinicians (and witnessing lawyers), and 
outline clear directions to determine capacity and when capacity is lost.  It should be made 
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clear that practitioners do not have to agree with the treatment preference specified.  It should 
also specify exemplary procedures to follow if there is PAD enforcement issues such as 
revocation. 
2 Support for service users and their whānau 
The Ministry of Health must update their pamphlet to include a good practice PAD template.  
While easy to follow information on PADs already exists on the website, the importance of 
the following PAD content should be stressed: 
 the scope and good-faith spirit of a PAD; 
 that while PADs do not have to be made with anyone other than the patient, making 
PADs with other trusted people will give the service user the best chance of having it 
enforced; 
 that all treatment preferences should include sufficient reasoning to ensure the best 
chance of it being complied with by a clinician; 
 that while witnesses are not required to make a PAD valid, it is strongly encouraged 
that PADs are witnessed by a clinician or lawyer (or if not, by whānau) to provide 
evidence to an acting clinician that the PAD was made with the requisite capacity; 
 update and promote pre-existing PAD templates. 
Website information should be made available in audio or presentation video form.
260
  This is 
able to engage with all sectors of society who have mental illnesses, even those with reading 
and language disabilities.   
3 Support for advocates, NGOs, and peer support groups 
A key finding established from Part VI is that consumer advocates, NGO service providers, 
and peer support work are usually the first points of PAD introduction for service users.  The 
Health and Disability Commissioner should encourage and provide resource assistance to 
advocates, community organisations, and peer support to launch a targeted national education 
programme about PADs for service users.  These community organisations are able to 
develop a better relationship with service users, who are more likely to be in a place to plan 
for future crises.  Again, this seeks to empower the individual and their whānau to understand 
a PAD for themselves.   
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C Access  
1 Lodging PADs in the EHR 
A truly effective system will have the infrastructure for clinicians to quickly access a PAD (if 
any exists) every time a patient is admitted for emergency care.  Service users should be able 
to approach a DHB clinician (or their GP to lodge with the DHB) to have their PAD filed in 
their EHR records. Simultaneously a yellow flag should be outlined at the top of the patient’s 
medical records to bring the clinician’s attention to the AD within the records.   
4 National database 
In the long-term, it is recommended that the Ministry of Health create a nation-wide register 
for ADs of all kinds.  This would be particularly helpful in situations where a patient is 
brought to a hospital that is unfamiliar with the patient’s medical history, and is unable to 
verify whether the patient has a PAD based on their NHI file.  This would also allow the 
Ministry of Health to monitor the use and enforcement of PADs, and the potential benefits, 
over time. 
XI Conclusion 
When utilised to their full potential, PADs are a sophisticated platform that ensures the 
patient’s autonomous voice is considered at a time when they are most vulnerable.  Overall, 
New Zealand service providers and patients are positive about using PADs and willing to 
better understand them.  However practical mechanisms needed to support PAD enforcement 
is lacking.  PADs are not well-promoted to patients that would benefit from them, clinicians 
do not routinely inquire into whether a patient has a PAD, and access to PADs in crisis time 
is inefficient.  No jurisdiction to date has fully recognised the power of peer support groups 
and advocates in promoting and educating service users to make PADs.    
Accordingly, PAD literacy of service users and their families must be improved. This 
improvement should be championed by advocates, NGOs and community support groups.  
To match this, the literacy of clinicians in enforcing PADs must also increase.  The impetus 
to achieve this may emanate ‘top-down’ from legislative change.  However, this must be 
supplemented by a ‘bottom-up’ education programme from guidelines which fill the gaps and 
aims to create a receptive service culture.  
54 
 
Ultimately, any recommendations for legal and policy change will have limited impact if 
stakeholders do not appreciate the collaborative value of PADs; if clinicians do not respect 
and understand the potential for them to facilitate good practice, and patients have no 
confidence in PAD enforcement.  This paper hopes to reinvigorate the discourse promoting 
PADs that was initiated by the Mental Health Commission in the early 2000s.  In a system 
promotes the axiom “nothing about us without us”, PADs are the vehicle to maximising 
patient involvement in mental health treatment. 
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Appendix 1: Proposed parts to be added to the Mental Health (Compulsory 
Assessment and Treatment) Act 1992 
 
Section 2: Interpretation 
Advance Directive means a written or oral directive –  
(a) by which a person makes a choice about a possible future health care procedure; and 
(b) that is intended to be effective only when he or she is not competent. 
 
Section 70A: Right to have an Advance Directive considered  
(1) Every person, upon becoming a patient, who has made an Advance Directive shall have 
their wishes specified in that Advance Directive considered by any person giving 
medical treatment authorised by virtue of this Act.  
(2) The responsible clinician giving medical treatment authorised by virtue of this Act shall 
take reasonable steps to locate the Advance Directive.  
(3) The responsible clinician who makes the final decision to follow or not follow an 
Advance Directive shall –  
(a) record in writing the circumstances in which the decision was authorised, given or 
made or, as the case may be, not authorised, given or made, and the reasons why; and 
(b) supply 
(i) the person who made the Advance Directive; and 
(ii) the name of the responsible clinician; and 
(iii) the name of any other clinician who gave a second opinion where 
applicable; 
with a copy of that record; and  
(c) place a copy of that record with that person’s medical records. 
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Appendix 2: HDC Pamphlet Short Exemplar 
 
Example of an advance directive refusing drug X
261
 
 
I _______________________ do not wish to receive drug X under any circumstances.  I have 
discussed this decision with my psychiatrist, Dr _____________, who has explained my 
treatment options and the expected benefits, risks and side effects of drug X.  I confirm that I 
have made this decisions of my own free will and that, unless revoked by me, this is to apply 
for the next _________ years.  
 
Date _________________________ 
Signature _____________________________ 
 
I confirm that _____________________ is competent at the time of making this advance 
directive. 
Date ______________________ 
Clinician ___________________________ 
  
                                               
261 Health and Disability Commissioner “Advance Directives in Mental Health Care and Treatment: Information 
for mental health service users” Mental Health Commission < www.hdc.org.nz>. 
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Appendix 3: New Zealand Medical Association General AD Form 
 
ADVANCE DIRECTIVE262 
 
I…………………………………………………………………………………………….  
of……………………………………………………………………………………………  
advise that in any circumstance that I am not competent to make a choice about a 
future healthcare procedure, should the following situation arise:  
………………………………………………………………………………………………….
…………………………………………………………………………………………………
………….………………………………………………………………………………………
…………………….……………………………………………………………………………
……………………………….…………that I accept/decline/withdraw (delete those 
which are not applicable) the following treatment/s 
………………………………………………………………………………………………….
…………………………………………………………………………………………………
………….………………………………………………………………………………………
…………………….……………………………………………………………………………
……………………………….………… 
 
I confirm that information about the risks, consequences and treatment options of my 
decision were given (summarise below):  
………………………………………………………………………………………………….
…………………………………………………………………………………………………
………….………………………………………………………………………………………
…………………….……………………………………………………………………………
……………………………….…………………………………………………………………
………………………………………….………………………………………………………
…………………………………………………….……………………………………………
……………………………………………………………….………… 
 
Name of usual doctor (or Medical Practitioner with the closest relationship with the 
patient)  
………………………………………………………………………………………………….
………… 
Signed………………………………………………………………………….…(Patient)  
 
Signed………………….…………………………………………………………(Doctor)  
 
Witnessed…………….………………………………………………….(Contact Person)  
 
Date…………………………………………………..  
 
Updated/reconsidered/endorsed on ………………………………………  
 
Updated/reconsidered/endorsed on……………………………………….  
  
                                               
262 New Zealand Medical Association “Advance Directives” (2007) New Zealand Medical Association website 
<www.nzma.org.nz/>. 
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Appendix 4: Exemplar of a Wellness Plan  
  
Appendix 5: Current differences between the PADs and Treatment/ Discharge/ 
Wellness Recovery Action Plans (WRAP) 
 
PADs Treatment/ Discharge/ WRAP plans 
 
 Made voluntarily, free from undue 
pressure 
 ‘Belongs to’ the person  
 Focus on treatment  
 Do not need approval or endorsement by 
anyone, including clinicians and family 
members 
 Legal status under common law, with 
processes for redress available  
 Primary focus on informed consent  
 
 Made to conform to best practice 
standards/ and or Ministry of Health 
requirements 
 ‘Belongs to’ the mental health service 
involved. 
 Usually reflects a consensus of the 
clinical team, agreement of the service 
user and possibly family. A regulatory 
requirement for providers 
 Primary focus on optimum, co-ordinated 
care 
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Appendix 6: Ethics approval form 
 
HUMAN ETHICS COMMITTEE 
Application for Approval of Research Projects 
Please write legibly or type if possible. Applications must be signed by supervisor (for 
student projects) and Head of School 
Note: The Human Ethics Committee attempts to have all applications approved within three weeks 
but a longer period may be necessary if applications require substantial revision. 
1. NATURE OF PROPOSED RESEARCH: 
(a) Staff Research/ Student Research (delete one) 
(b) If Student Research ……..... Degree ……LLB (Hons)… Course Code: LAWS513 
(c) Project Title: Psychiatric Advance Directives  
 
2. INVESTIGATORS: 
(a) Principal Investigator 
Name ………Grace Liang….…….…………………………… 
Email address ………lianggrac@myvuw.ac.nz……………………….………………………... 
School/Dept/Group ……Faculty of Law………………….…………….…….. 
(b) Other Researchers  Name    Position 
………………………………………………………….……………….…………………………………………………..…….. 
………………………………………………………………………….…….……………………………………………..…….. 
(c) Supervisor (in the case of student research projects) 
……Prof Bill Atkin………………….…….……………………………………………..…….. 
3. DURATION OF RESEARCH 
(a) Proposed starting date for data collection ……after date of approval………………..…….. 
(Note: that NO part of the research requiring ethical approval may commence prior to approval 
being given) 
(b) Proposed date of completion of project as a whole …………1 October 2013………………… 
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4. PROPOSED SOURCE/S OF FUNDING AND OTHER ETHICAL 
CONSIDERATIONS 
(a) Sources of funding for the project 
Please indicate any ethical issues or conflicts of interest that may arise because of sources of funding 
e.g. restrictions on publication of results 
No external funding required 
(b) ) Is any professional code of ethics to be followed N  
If yes, name 
………………………………………………………………………………………..…………………………………………… 
(c)  Is ethical approval required from any other body N  
If yes, name and indicate when/if approval will be given 
………………………………………………………………………………………………………..…………………………… 
5. DETAILS OF PROJECT 
Briefly Outline: 
(a) The objectives of the project 
I have chosen to focus my research on Psychiatric Advance Directives (PADs), with 
the objective of better understanding the extent that PADs are used in New Zealand, 
and ascertaining the benefits and costs of strengthening the legal framework around 
PADs.  I hope to develop a “good practice” guide which will facilitate the use of PADs 
in New Zealand. 
These interviews will help me better understand the role of psychiatrists/ mental 
health workers in mental health organisations, whether and how PADs feature - or 
could feature - in their work.  
(b) Method of data collection 
Mixture of face-to-face interviews and phone interviews.  These interviews will be audio recorded with 
the interviewee’s consent to capture missing details from notes taken during the interview. 
(c) The benefits and scientific value of the project 
While there has been legal literature on advance directives, there remains very little written on 
advance directives in the psychiatric field, and even less from a New Zealand perspective.  Directives 
are becoming increasingly important in psychiatry, but there is insufficient publically available 
information for patients and loose guidelines for mental health workers.  One of the objectives of this 
paper is to develop a good practice guideline, with recommendations for potential law reform. 
(d) Characteristics of the participants 
Between 6-8 medical professionals will be interviewed – e.g. psychiatrists, mental health workers.  I 
will try to select interviewees from a range of different ethnicities, and from different types of clinics 
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within the Wellington region (for instance, community mental health clinics, co-morbid mental health 
rehabilitation, Crisis Assessment Treatment Team) 
(e) Method of recruitment 
Using existing contacts and general requests through email. 
(f) Payments that are to be made/expenses to be reimbursed to participants 
Not applicable 
(g) Other assistance (e.g. meals, transport) that is to be given to participants 
Not applicable 
(h) Any special hazards and/or inconvenience (including deception) that participants will 
encounter 
There is a risk that an interviewee may mention or identify a patient.  It will be made clear to the 
interviewee prior to the interview that I am not asking for any such (identifying) information.  If a 
participant does mention a patient, this will not be recorded in the interviewer’s notes. 
(i) State whether consent is for (delete where not applicable): 
(i) the collection of data 
(ii) attribution of opinions or information 
(iii) release of data to others 
(iv) use for a conference report or a publication 
(iv) use for some particular purpose (specify) 
Research paper ……………………………………………………………….…………………… 
…………………………………………………………………………………………………….…………………… 
Attach a copy of any questionnaire or interview schedule to the application  
(j) How is informed consent to be obtained (see sections 4.1, 4.5(d) and 4.8(g) of the 
Human Ethics Policy) 
(i) the research is strictly anonymous, an information sheet is 
supplied and informed consent is implied by voluntary 
participation in filling out a questionnaire for example (include 
a copy of the information sheet) 
N  
(ii) the research is not anonymous but is confidential and informed 
consent will be obtained through a signed consent form (include 
a copy of the consent form and information sheet) 
Y  
(iii) the research is neither anonymous or confidential and informed 
consent will be obtained through a signed consent form (include 
a copy of the consent form and information sheet) 
N  
(iv) informed consent will be obtained by some other method 
(please specify and provide details) 
N  
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…………………………………………………………………………………………………….…………………… 
…………………………………………………………………………………………………….…………………… 
With the exception of anonymous research as in (i), if it is proposed that written consent will 
not be obtained, please explain why 
…………………………………………………………………………………………………….…………………… 
…………………………………………………………………………………………………….…………………… 
(k) If the research will not be conducted on a strictly anonymous basis state how issues of 
confidentiality of participants are to be ensured if this is intended. (See section 4..1(e) of 
the Human Ethics Policy). (E.g. who will listen to tapes, see questionnaires or have 
access to data). Please ensure that you distinguish clearly between anonymity and 
confidentiality. Indicate which of these are applicable. 
(i) access to the research data will be restricted to the investigator N 
 
(ii) access to the research data will be restricted to the investigator 
and their supervisor (student research) 
Y  
(iii) all opinions and data will be reported in aggregated form in 
such a way that individual persons or organisations are not 
identifiable 
N  
(iv) Other (please specify)  
Publication of information will not single-out any individual.  If individuals are quoted, no 
names will ever be used (Instead, it will be worded for example ‘one [person] stated…”) 
 
(l) Procedure for the storage of, access to and disposal of data, both during and at the 
conclusion of the research. (see section 4.12 of the Human Ethics Policy). Indicate which 
are applicable: 
(i) all written material (questionnaires, interview notes, etc) will be 
kept in a locked file and access is restricted to the investigator 
Y  
(ii) all electronic information will be kept in a password-protected 
file and access will be restricted to the investigator 
Y  
(iii) all questionnaires, interview notes and similar materials will be 
destroyed: 
 
 (a) at the conclusion of the research N  
 (b)……2…….years after the conclusion of the research; or Y  
(iv) any audio or video recordings will be returned to participants 
and/or electronically wiped 
Y  
(v) other procedures (please specify):  
See (ii) below – Supervisor will also have access to the research 
data. 
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…………………………………………………………………………………………………….…………………… 
…………………………………………………………………………………………………….…………………… 
If data and material are not to be destroyed please indicate why and the procedures envisaged 
for ongoing storage and security 
…………………………………………………………………………………………………….…………………… 
…………………………………………………………………………………………………….…………………… 
…………………………………………………………………………………………………….…………………… 
(m) Feedback procedures (See section 7 of Appendix 1 of the Human Ethics Policy). You 
should indicate whether feedback will be provided to participants and in what form.  If 
feedback will not be given, indicate the reasons why. 
Participants can indicate on the participant consent form if they wish to receive a 
copy of the finished research paper.  This will be emailed to them after the conclusion 
of the research. 
(n) Reporting and publication of results. Please indicate which of the following are 
appropriate. The proposed form of publications should be indicated on the information 
sheet and/or consent form. 
(i) publication in academic or professional journals Y  
(ii) dissemination at academic or professional conferences Y  
(iii) deposit of the research paper or thesis in the University Library 
(student research) 
Y  
(iv) other (please specify) N  
…………………………………………………………………………………………………….…………………… 
…………………………………………………………………………………………………….…………………… 
Signature of investigators as listed on page 1 (including supervisors) and Head of School. 
NB: All investigators and the Head of School must sign before an application is 
submitted for approval 
……………………………….………………………………………  Date…………………….………... 
……………………………….………………………………………  Date…………………….………... 
……………………………….………………………………………  Date…………………….………... 
Head of School: 
……………………………….………………………………………  Date…………………….………... 
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Appendix 7: Information Sheet for Participants 
 
 
 
 
Information sheet for Participants 
Research on Psychiatric Advance Directives for LAWS513 Law and 
Medicine Research Paper 
 
1) Introduction 
My name is Grace Liang, and I am a final year Bachelor of Law (Hons) student at 
Victoria University of Wellington.  I am currently writing my 15,000 word research 
paper for LAWS513, a special topic paper on Law and Medicine taken as part of the 
Honours programme. 
 
I have chosen to focus my research on Psychiatric Advance Directives (PADs), with 
the objective of better understanding the extent that PADs are used in New Zealand, 
and ascertaining the benefits and costs of strengthening the legal framework around 
PADs.  I hope to develop a “good practice” guide which will facilitate the use of PADs 
in New Zealand. 
 
These interviews will help me better understand the role of psychiatrists/ mental 
health workers in mental health organisations, whether and how PADs feature - or 
could feature - in their work.  
 
As well as providing an indication of what mental health workers already know about 
PADs, the questions I would like to ask you pose hypothetical scenarios to 
understand whether you think PADs will provide any benefits to patients as well as 
mental health workers, and in what circumstances you would use them.  
 
Victoria University of Wellington’s Human Ethics Committee has approved this 
research.  If you choose to participate after reading this information sheet and 
clarifying any questions, you will be asked to sign a consent form.   
 
2) Methodology 
 
I will interview a small number of experienced mental health workers from various 
organisations within the Wellington region.  There will be a mixture of face-to-face 
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interviews and phone interviews.  All interviews will be audio-recorded, and written 
notes taken during the interview.  Interviews will not take longer than 60 minutes.  
 
3) Role of the participant 
Personal details of participants and information provided by participants will be 
treated as confidential.  Note that I am not requesting any information about any 
patients you may have dealt with.  Publication of information will not single-out any 
individual.  If individuals are quoted, no names will ever be used (Instead, it will be 
worded for example ‘one [person] stated…”) 
 
4) Rights of the participant 
 
Participants will have the right to check the interview notes, and specify that certain 
comments not be used for research purposes.  Participants have the right to 
withdraw from the research within two week after receiving the notes to check, after 
which I will assume that person will not withdraw.  If a participant chooses to 
withdraw, all data collected will be destroyed.    
Please indicate on the participant consent form if you wish to receive a copy of the 
finished research paper.  This will be emailed to you after the conclusion of the 
research. 
 
5) Treatment of data 
Access to research data will be restricted to me (the student researcher) and my 
supervisor, Bill Atkin.  All information collected will be treated as confidential, and will 
be protected by secure storage methods.  Raw information collected including audio 
recordings will be kept for two years, from which time it will be destroyed.   
 
6) Publication of data 
Information collected from interviews will be analysed for the 15,000 word research 
paper. A chart collating the responses to the questions may be included in an 
appendix to the paper, but this data will be presented in a way that will not identify 
the individual participants. 
This paper is to be handed in to the Faculty of Law on the 1 October 2013, and a 
copy of the research paper will be held permanently in the Victoria University Library 
(for student research purposes). An edited version may be published in academic or 
professional journals or be used at a conference. 
 
7) Contact Details 
Student Researcher 
Grace Liang 
lianggrac@myvuw.ac.nz 
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Cell: 027 340 1103 
Landline: (04) 801 7598 
 
Supervisor 
Prof Bill Atkin 
Bill.atkin@vuw.ac.nz 
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Appendix 8: Participant Consent Form 
 
 
 
PARTICIPANT CONSENT FORM 
Interview on Psychiatric Advance Directives for LAWS513 Law and Medicine 
Research Paper by Grace Liang 
 
I, _________________________, in participating in this research project 
 have been provided with adequate information relating to the nature and objectives of 
this research project, I have understood the information provided to me and have 
been given the opportunity to seek further clarification; 
 understand that I may withdraw from this research within two week after receiving 
interview notes to check;   
 understand that if I withdraw from the project, any data I have provided will be 
destroyed; 
 understand that information or opinions I provide will be kept confidential and 
reported in a way that will not identify any individual person; 
 understand that should a patient be identified in the interview process, the name will 
not be recorded in any interview notes or transcripts; 
 understand that the information I have provided will be used only for this research 
project and that any further use will require my written consent; 
 understand that when this research is completed the information obtained will be 
destroyed after two years. 
I would like a copy of the research paper emailed to me  
Email address _________________________________ 
 
Signature 
 
Date 
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Appendix 9: Interview Questions on Psychiatric Advance Directives  
 
Interview Questions  
Research on Psychiatric Advance Directives for 
LAWS513 Law and Medicine Research Paper 
 
Interview Questions 
1. Explain what your day-to-day role is at [organisation X]. 
 
2. What type of patients do you work with? (If possible, specify the type of mental 
illnesses you deal with most). 
 
3. Describe what you know about Psychiatric Advance Directives (PADs)  
 
4. Where did you learn about PADs?  
 
5. Have you had any formal education in PADs (formal meaning any tertiary education 
or training) 
 
6. What do you think is the general attitude of clinicians AND patients to the idea of 
making and implementing PADs?  
 
7. Have you ever recommended that a patient make a PAD? 
 
8. Have any of your previous patients ever requested a PAD?  
 
9. Have you ever helped a patient complete a PAD? 
 
10. If no Q9, why have you not recommended a PAD previously? 
 
11. Have you ever had to apply a PAD in a crisis scenario (treat someone using a PAD)? 
 
12. If yes to Q10, did you follow the PAD?  To what extent did you follow the PAD? 
 
13. In your experience, what type of PADs have you encountered? Try and describe the 
content and form without identifying the patient. 
Start here if answered “no” to Q8 [or continue on from Q13] 
14. Would you ever recommend that a patient make a PAD? 
 
15. If yes, what type of patients would you recommend make a PAD? In what 
circumstances would it be appropriate for clinicians to recommend PADs? 
 
16. Should different types of PADs apply to different patients? (e.g. PADs for specific 
treatment vs more vaguely worded PADs). 
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17. If you were to recommend that a patient make a PAD, can you describe the process 
you would go through with the patient? What sorts of things do you think could be 
included in a PAD? What sorts of things should be excluded? 
 
18. Does the organisation/ clinic that you work for have a PAD regime? (e.g. a form to fill, 
information pamphlet, anything quasi-PAD?) 
 
19. What do you understand about the legal standing of PADs in New Zealand? (what 
legal force do PADs have in NZ?) 
 
20. In your work, what are the benefits of having and promoting the use of PADs?  
a. For clinicians? 
b. For nurses? 
c. For patients themselves? 
 
21. Do you personally have any reservations about the process: 
a. Making a PADs? [capacity; form etc] 
b. Changing/altering/monitoring PADs? 
c. Enforcing PADs? 
Why do you hold these reservations?   
 
22. In your work, what would be costs/ obstacles/ barriers of having/ implementing 
PADs?  
a. For clinicians? 
b. For nurses? 
c. For patients themselves? 
 
23. Based on your answer to Q20 and 21, do you think more patients should make PADs 
where appropriate? 
 
24. Do you think legally binding PAD orders would be workable? 
a. In what circumstances? 
 
25. Do you think PADs need a stronger framework or governing standard in New 
Zealand? Should there be a duty on doctors to inform? 
If yes, in what situations? 
1. All? 
2. Most serious cases? 
3. People who have been subject to compulsory care previously? 
 
26. Should there be a “good practice” guide developed for clinicians? 
 
27. Should there be a standard “form” or should we allow individual hospitals to create 
their own? 
 
 
